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Survivors of medical and surgical intensive care units (ICUs) are at high risk for long-lasting 
cognitive impairments. Among critical illnesses that can induce cognitive deficits, sepsis is 
commonly regarded as the most frequent and severe cause, considering one out of three 
survivors of sepsis is discharged from hospital with severe de novo cognitive impairment. 
Chronic neuroinflammation, diffuse cerebral damage and neuronal death are considered 
primary correlates in the development of long-term cognitive deficits. Recent studies have 
suggested sepsis can cause inflammatory activation of the microglia, which lead to microglial 
phagocytosis of stressed but viable neurons.  
To establish a mouse model of sepsis, lipopolysaccharide (LPS) at a dose of 
1.5 mg/kg was injected in C57BL/6 mice and homozygous knockout and wildtype mice that 
are deficient for Mertk, Cd11b and Mfge8. Immediate sickness behavior and long-term 
cognitive functions of animals were analyzed to assess the effects of phagocytic deficiency 
and peptide treatments on cognitive deficits. To best meet the requirements of animal welfare 
by minimizing repetitive handling, water and/or food restriction and unnecessary suffering, 
we have also investigated the applicability of a fully automatized 8-arm radial arm maze 
(RAM) and machine learning-based humane endpoint determination.  
LPS-injected animals have displayed (a) characteristics of sickness behavior 
immediately following the injections, and (b) cognitive deficits after the one-month recovery 
period. Animals deficient for Mertk, Cd11b or Mfge8 have displayed greater learning 
performances during place learning, place reversal and avoidance conditioning. Treatment 
effects of Cilengitide or cRGD were observed in sucrose preference, avoidance conditioning 
and the early stage of place learning. In the meantime, using humane endpoints determined 
with machine learning models, mice of both stroke and sepsis model that are at higher risk 
of death could be detected at a high accuracy. Mice up to 18 months of age have shown 
efficient spatial learning in both working memory and combined working/reference memory 
paradigms in the automated 8-arm RAM without food and/or water restriction.  
With a mouse model of sepsis, alleviation of long-term cognitive deficits could be 
observed in phagocytic deficient animals and Cilengitide- or cRGD-treated animals, which 
might offer an explanation of underlying mechanisms of long-term cognitive deficits following 
systemic inflammation. Minimized suffering for animals and improved reproducibility of 
experimental outcomes were possible using machine learning-based endpoint determination 














Überlebende von chirurgischen und konservativen Intensivstationen haben ein hohes Risiko 
für lang anhaltende kognitive Defizite. Die Sepsis gilt als häufigste und schwerwiegendste 
der kritischen Erkrankungen, die zu kognitiven Defiziten führen können. Einer von drei 
Überlebenden einer Sepsis wird mit schwerer, neu aufgetretener kognitiver Dysfunktion aus 
dem Krankenhaus entlassen. Chronische Neuroinflammation, diffusive zerebrale 
Schädigungen und neuronaler Zelltod werden als die primären Korrelate in der Entwicklung 
lang anhaltender kognitiver Defizite angesehen. Neuere Studien deuten darauf hin, dass 
Sepsis eine inflammatorische Aktivierung von Mikroglia auslöst, die zu Phagozytose 
gestresster, aber funktionsfähiger Neurone führt. 
Um ein Mausmodell der Sepsis zu etablieren, wurden Lipopolysaccharide (LPS) in 
C57BL/6-Mäuse und homozygote Knockout- und Wildtyp-Mäuse mit Mertk-, CD11b- und 
Mfge8-Defizienz in einer Dosierung von 1,5mg/kg injiziert. Das akute Krankheitsverhalten 
und langzeitige kognitive Funktionen der Tiere wurden analysiert, um die Effekte von 
phagozytotischer Defizienz und Behandlung mit Peptiden auf kognitive Defizite zu 
untersuchen. Um die Anforderungen an das Tierwohl durch Reduzierung von Handling, 
Wasser- und/oder Nahrungsentzug und unnötigem Leid optimal zu erfüllen, untersuchten wir 
außerdem die Anwendbarkeit eines vollständig automatisierten 8-Arm-Radial Arm Mazes 
und von machine learning-basierter Bestimmung von Abbruchkriterien (humane endpoints). 
Tiere mit LPS-Injektion zeigten (a) Charakteristika von Krankheitsverhalten 
unmittelbar nach der Injektion und (b) kognitive Defizite nach der einmonatigen 
Erholungsperiode. Tiere mit Mertk-, CD11b- und Mfge8-Defizienz präsentierten bessere 
Lernleistungen bezüglich Place Learning, Place Reversal und Avoidance Conditioning. 
Behandlungseffekte von Cilengitid oder cRGD konnten bezüglich Sucrose Preference, 
Avoidance Conditioning und in der frühen Phase des Place Learning beobachtet werden. 
Bei der Nutzung von Machine Learning-Modellen, die Abbruchkriterien bestimmten, zeigte 
sich, dass Mäuse im Schlaganfall- und im Sepsismodell mit einem höheren Todesrisiko mit 
hoher Genauigkeit erkannt werden konnten. Mäuse bis zum Alter von 18 Monaten zeigten 
effizientes räumliches Lernen im Paradigma für das Arbeitsgedächtnis und im kombinierten 
Paradigma für das Arbeits- und Referenzgedächtnis im automatisierten 8-Arm-Radial Arm 
Maze ohne Nahrungs- oder Wasserentzug. 
In einem Mausmodell der Sepsis beobachteten wir eine Verminderung langzeitiger 
kognitiver Defizite in phagozyten-defizienten und in Cilengitid- oder cRDG-behandelten 
Tieren, was eine Erklärung für die Mechanismen, die langzeitigen kognitiven Defiziten 
zugrunde liegen, bieten könnte. Minimiertes Leid für die Tiere und verbesserte 
Reproduzierbarkeit von experimentellen Ergebnissen waren möglich durch die Benutzung 











1.1. Motivation and clinical relevance 
Survivors of intensive care units (ICUs) are at high risk for long-term, de novo cognitive 
deficits of memory, attention and executive functions (Pandharipande et al., 2013). Failure 
in regaining full cognitive functions has affected 30-70% of ICU survivors at one year after 
discharge. Among critical illnesses that lead to cognitive deficits, sepsis is regarded as the 
most common cause (Widmann and Heneka, 2014). Magnetic resonance imaging studies 
have associated post-sepsis white matter disruption of the frontal cortex and hippocampus 
with long-term cognitive deficits in human survivors (Semmler et al., 2013) and studies on 
human post-mortem brains have identified an association between systematic infection and 
microglial activation (Lemstra et al., 2007). Therefore, it would be crucial to understand the 
role of microglial activation in neuronal loss and associated cognitive alterations.  
 
1.2. Microglial phagocytosis and phagoptosis 
Microglia are specialized macrophages which are responsible for phagocytic removal of 
pathogens, cell debris and dying cells, thus play an essential role in immune defense in the 
central nervous system (CNS). For a cell to be removed, an “eat-me” signal need to be 
displayed on its surface (Ravichandran, 2011; Figure 1.1). Phagocytic removal of neurons is 
commonly considered as a beneficial process which only occurs after neuronal death (Neher 
et al., 2013). Nonetheless, recent findings have revealed possible removal of viable neurons 
by phagocytosis ("phagoptosis”; Brown and Neher, 2012). Under inflammatory conditions, 
phagoptosis could lead to stressed viable neurons to be executed (Fricker et al., 2012).  
Upon inflammatory activation using lipopolysaccharide (LPS), reversible exposure of 
a “eat-me” signal phosphatidylserine (PS) induced by activated microglia is observed on the 
surface of viable neurons, leading to possible removal (Neher et al., 2013). When microglia 
are present, PS externalization eventually lead to neuronal death. In the absence of microglia, 
PS externalization could be reversed (Neher et al., 2013).  
 
1.3. Phagocytic deficiency, inhibition of phagocytic signaling pathways and 
possible alleviation of neuronal loss 
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Neuronal PS could be recognized through microglial transmembrane receptors (direct 
recognition) or binding of soluble opsonins (indirect recognition), including milk fat globule 
EGF-like factor 8 protein (Mfge8), growth arrest specific gene 6 (Gas6) and Protein S. Gas6 
and Protein S bind to exposed PS on neurons and are recognized by the membrane protein 
Mer receptor tyrosine kinase (Mertk). Opsonins such as complement components C1q and 
C3 play a central role in synaptic pruning or pathological situations (Schafer et al., 2012). 
C1q can also induce the conversion of C3 to C3b, and consequently recognition of the 
opsonized neuronal structure by complement receptor 3 (CR3), consisting of a cluster of 
differentiation molecule 11b (CD11b) and CD18. Microglial phagocytosis of the “eat-me” 
signal exposing neurons will occur as a result of activation of lipoprotein receptor-related 
protein or CR3 (Linnartz et al., 2012).  
 
Figure 1.1: “Eat-me” signals, “don’t eat-me” signals and signaling pathways in the regulation of 
phagocytosis of neurons and neuronal structures (Brown and Neher, 2014). 
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Previous study showed reduced neuronal loss and improved neuronal survival in LPS-
injected Mfge8 knockout mice (Fricker et al., 2012). In a rodent model of mild focal cerebral 
ischemia, mice deficient for Mfge8 or Mertk showed reduced brain atrophy and preserved 
sensorimotor functions along with effectively blocked phagocytosis (Neher et al., 2013). To 
understand the effect of phagocytic deficiency on long-term cognitive abilities, in this study, 
animals deficient for Mertk, Cd11b and Mfge8 were used and compared with wildtype 
animals. 
It has been shown that inhibition of phagocytic signaling pathways may lead to 
increased neuronal survival following focal cerebral ischemia (Emmrich et al., 2017). In this 
study, animals were treated with Cilengitide for inhibition of phagocytic signaling, or inactive 
control peptide cRGD. Performance in cognitive tasks of Cilengitide-, cRGD-treated and 
untreated animals was assessed to examine long-term behavioral outcomes of inhibition of 
phagocytic signaling pathways. 
 
1.4. Mouse model of LPS-induced sepsis and sickness behavior 
Sickness behavior is defined as the immediate behavioral responses to pro-inflammatory 
mediators acting on the brain, which could be induced with LPS in a systemic inflammation 
model. In rodent models of acute illnesses, sickness behavior including decreased motor 
activity, lethargy, reduced food and water intake, reduced response to stimulus and altered 
cognitive functions could be observed (Dantzer et al., 2008).  
A primary component of sickness behavior during LPS administration is short-term 
behavioral alterations that only last for hours or days. Long-term affective, behavioral and 
cognitive alterations may occur after a recovery period (Anderson et al., 2015). Previous 
studies have identified neuronal and synaptic loss associated with long-term cognitive 
deficits (Semmler et al., 2008), as well as early and sustained microglial activation, following 
peripheral LPS injection (Anderson et al., 2015). Although sickness behavior disappears 
within days following LPS injection, long-term cognitive alterations may still be present, 
making mouse model of LPS-induced sepsis ideal for studying long-term cognitive deficits. 
 
1.5. Determination and refinement of humane endpoints 
 14 
Among animal models of sepsis, mouse models are widely used because of the large 
number of available genetically-engineered strains and the lower cost. Due to the nature of 
animal models of acute disease, high level of suffering and discomfort for experimental 
animals has been a concern in the implementation of the Three Rs (replacement, reduction 
and refinement; Russell, Burch and Hume, 1959). Accordingly, following the induction of 
acute disease, a method to identify animals at higher risk of death at an early time point to 
minimize unnecessary suffering is highly desired. To identify the endpoint by which 
experiments should be terminated without compromising data quality and interpretation, 
humane endpoints, a substitute for more severe experimental outcome such as spontaneous 
death, were introduced and applied in various animal models of disease.  
However, among studies that reported the use of humane endpoints in animal models 
of disease, a high intra- and inter-model variance in endpoint determination and application, 
and a lack of performance metrics in the evaluation of humane endpoints have been 
observed (Mei et al., 2019). Given the varying nature of animal models, unstandardized 
protocols in inspection and heterogeneity of previously used humane endpoints, accurate 
determination of humane endpoints remains challenging. Therefore, alternative methods to 
determine humane endpoint are needed to improve interpretability and reproducibility of 
research with animal models of sepsis, and to better meet the requirements of animal welfare. 
 
1.6. Behavioral testing using a fully automated 8-arm radial arm maze 
In experimental research, mazes are used to determine an animal’s cognitive characteristics 
such as memory and attention. The radial arm maze (RAM) has been widely used in the 
study of spatial learning and memory since first described in 1976 (Olton and Samuelson, 
1976). The RAM generally consists of a central platform from which 4-8 arms radiate 
outwards, each could be reward-baited with food, sugar pellets or water. Pre-experimental 
habituation is required to familiarize animals with the setup, during which an animal is placed 
on the central platform of the RAM for freely exploring the RAM and familiarizing with rewards 
in the baited radial arms. During experiments with the RAM, a reward is placed by the end 
of each radial arm (working memory paradigm) or selected arms (combined 
working/reference memory paradigm), and animals are required to remember the location of 
baited and visited arms to optimally obtain rewards.  
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In experiments with RAM, animals are usually food or water-restricted for prolonged 
periods of time to achieve sufficient motivation, which causes reduced body weight and 
altered appetite and may affect an animal’s foraging strategy (Vorhees and Williams, 2014). 
A number of studies have also suggested learning outcomes could be affected by the level 
of motivation and food or water restriction (Pesic et al., 2010; Johansson et al., 2008; 
Vorhees and Williams, 2014) and revealed that water- or food-deprived animals may have 
different response patterns to the behavioral task (Reberg, Mann and Innis, 1977). Food or 
water restriction may lead to different motivation levels and learning outcomes, therefore 
potentially reduce reproducibility and interpretability of experimental results. 
According to published studies, even minimal handling can induce stress that may 
create changes in animal behavior (Schellinck, Cyr and Brown, 2010; Hurst and West, 2010). 
Therefore, experiments with RAM which require a substantial degree of manual handling can 
have effects on stress responses that influence learning outcomes. As home-cage testing 
eliminates the need for handling (Schellinck, Cyr and Brown, 2010), it could lead to a 
promising alternative in behavioral testing with RAM. Although attempts have been made to 
automatize the RAM, the objectives were to ensure higher quality of data collection but not 
to fully meet the requirements of animal welfare, as food or water restriction was still broadly 
used. Therefore, to optimize interpretability and reproducibility of experimental results, 
minimized food and/or water restriction, reduced handling and home-cage testing are 
desirable.  
 
1.7. Aim of the study 
Microglial activation and phagocytosis may contribute to neuronal and synaptic loss during 
LPS-induced neuroinflammation. Following this assumption, we explored the role of 
deficiency of phagocytic pathways in post-sepsis behavior and cognitive alterations. The 
mouse model of experimental sepsis was established with intraperitoneal LPS injections in 
female homozygous wildtype C57BL/6 mice and female homozygous knockout and wildtype 
mice that are deficient for Mertk, Cd11b and Mfge8. To understand long-term cognitive 
alterations in LPS-injected mice, cognitive tests were performed following a one-month 
recovery period. For minimized handling-induced stress and unnecessary suffering, we also 
evaluated the use of automated behavioral testing systems and machine learning-
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determined humane endpoints in behavioral experiments and sickness behavior monitoring, 
respectively. Following that, in the present study, three sub-projects have been defined:  
1. Assessment of physiological and cognitive alterations in the mouse model of sepsis, 
and the effect of phagocytic deficiency or inhibition of phagocytic signaling pathways 
on cognitive functions; 
2. Refinement of humane endpoints in animal models of acute disease; and 


























2. Materials and methods 
2.1. Ethical statement 
Animal use in all experiments was approved by the Landesamt für Gesundheit und Soziales 
(LaGeSo), Berlin. Experiments were conducted in accordance with the German animal 
protection law and local animal welfare guidelines.  
 
2.2. Methods to prevent bias 
For the sepsis model, animals were randomized for treatment, measurement modality, and 
survival times using the Research Randomizer tool (https://www.randomizer.org). For the 
stroke model, animals were randomized for treatment group using the GraphPad calculator 
tool (https://www.graphpad.com/quickcalcs/randomize1.cfm).  
To minimize experimenter bias, randomization was conducted by a researcher who 
was not involved in injections, treatments, data acquisition or analysis. Information on strain, 
genotype and treatment group assignment was concealed from the experimenter until the 
end of the study.  
 
2.3. Sub-project 1: Assessment of physiological and cognitive alterations in the 
mouse model of sepsis, and the effect of phagocytic deficiency or inhibition of 
phagocytic signaling pathways on cognitive functions 
2.3.1. Animals 
Two-month-old female mice (n = 435; Table 2.1) were used and housed individually in 
custom-made polycarbonate cages (dimensions: 20 × 20 × 30 cm) for video recording or type 
III polycarbonate cages, from 2 days before treatments until the 4th days after treatments 
before transported back to homecages. Food and water could be accessed ad libitum. Room 
temperature was maintained at 23.0 ± 1.0 °C with a humidity of 55-65%. A 12:12 h light/dark 
cycle with lights on at 8:00 was used (dark phase: 8:00-20:00; light phase: 20:00-8:00). Wood 
chips were used as bedding. Mice were randomly assigned to treatment groups and were 
used in experiments at the age of 8-10 weeks. 
 
2.3.2. Drug administration 
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Animals were treated with LPS (from Salmonella enterica serotype, Sigma-Aldrich St. Louis, 
USA) at a dose of 1.5 mg/kg or physiological phosphate-buffered saline (PBS) solution 
through intraperitoneal administration on two consecutive days at 8:00 with a volume of 
10 μl/g. To investigate the effect of inhibition of phagocytic signaling pathways, Cilengitide 
(Cilengitide©, Selleckchem Inc.), a vitronectin receptor antagonist, or inactive control peptide 
cRGD (Peptide Special Laboratories, GmbH), or PBS (10 ml/kg), was administered 
intraperitoneally for 7 days following LPS injections. Cilengitide or control peptide at a dose 
of 30 mg/kg was injected 6 hours after the 1st LPS injection, followed by daily injections at a 
dose of 10 mg/kg.  
Strain  n  Origin 
C57BL/6J  55  Charles River Laboratories 
Mertk (B6;129-Mertktm1Grl/J)  126  The Jackson Laboratory 
Cd11b (B6;129-Mertktm1Grl/J, B6.129S4-Itgamtm1Myd/J)  126 Hertie Institute for Clinical Brain Research 
Mfge8  128 C. Théry, INSERM 932, France 
Table 2.1: Strain and origin of animals used in sub-project 1. 
 
2.3.3. Temperature transponder implant 
For temperature acquisition using radio-frequency identification (RFID) technology, passive 
RFID transponders were implanted subcutaneously. Temperature transponders (dimension: 
2 × 14 mm; model: IPTT-300 transponders; BioMedic Data Systems, Seaford, USA) were 
programmed with individual identification numbers, loaded in a needle applicator device, and 
sterilized prior to implantation. Three weeks before the first LPS or saline injection, 
temperature transponders were implanted subcutaneously in the region between the 
scapulae. Anesthesia was induced with 2% isoflurane delivered in 100% oxygen for < 45 s 
before the implantation and injected once with meloxicam (1 mg/kg; Sigma-Aldrich, USA) for 
analgesia. Mice were observed for up to 48 hours for signs of complications and 
transponders were checked weekly for presence and functionality before the experiments. 
 
2.3.4. Sickness behavior monitoring 
a. Timeline  
Baseline body temperature, weight and sickness severity score were obtained at 8:00 on the 
day of the 1st injection. During the two injection days and the two days following the 2nd 
injection, animals were inspected from 8:00 to 20:00. Body temperatures and sickness score 
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were obtained every 1.5 hours on each injection day. Body temperatures and sickness score 
were obtained every 6 hours for two days following the 2nd injection, and once per day at 
8:00 from post-injection day 3. Body weight was obtained every 6 hours during the two 
injection days and the first two days following the 2nd injection, then once per day at 8:00. 
b. Temperature acquisition 
Core temperature was measured with a non-contact handheld transponder reader (DAS-
7008/9; BioMedic Data Systems, Seaford, USA) held above the animal’s shoulder region. 
Two non-contact infrared thermometers (model 1: Braun No touch – NTF3000; Braun, 
Kronberg, Germany; model 2: Aponorm Contact Free 3; WEPA Aponorm, Hillscheid, 
Germany) were used in surface temperature measurement in the perianal region. 
c. Sickness severity scoring 
Sickness severity was scored on a scale of 0 - 5 (0: normal level of activity; 5: maximum 
sickness severity; Mei et al., 2018). 
d. Body weight measurements 
A bench scale was used (PCB 1000-1, KERN & SOHN GmbH, Balingen, Germany). Mice 
were weighed when both their body and tail were in a plastic box placed on the scale. Body 
weights were taken when a stable reading has been displayed. 
e. Video recording and nest scoring 
A GigE monochrome camera (DMK 33GR0134, The Imaging Source Europe GmbH, Bremen, 
Germany) was used. To reduce interference, body temperature and weight were measured 
with a 6-hour interval (at 8:00, 14:00 and 20:00). Sickness severity was scored every 1.5 
hours by observing the animals through the transparent lid of the cage. Ambulation distance 
and percentage of activity (time of ambulation divided by total time) were computed with 
automated tracking software (Viewer, Biobserve GmbH, Bonn, Germany). Scoring criteria of 
nest building behavior were adapted from Deacon (2006). Nest building was evaluated by 
two experimenters through the video daily at 8:00. The average score was used in the 
analysis. 
f. Humane endpoint 
Upon reaching a sickness severity score > 4 once, or a score = 4 twice within 2 hours, an 




Experiments started a month following LPS or saline injections and were conducted with 2 
IntelliCages (NewBehavior/TSE-Systems GmbH, Bad Homburg, Germany), in which mice 
were housed in original groups. IntelliCage is a homecage-based monitoring system that 
allows automated recording and assessment of spontaneous and cognitive behavior in 
transponder-implanted mice in a social setting without human interference (Lipp et al., 2005). 
An IntelliCage consisted four operant learning corners in each two water bottles were placed, 
with the nozzle behind a motorized door for programmable access to water. Food was 
accessible ad libitum.  
The experiment consisted of habituation (free exploration, nosepoke adaptation and 
drinking session adaptation) and cognitive testing (Figure 2.1). Free exploration allowed ad 
libitum access to water bottles. During nosepoke adaptation, animals needed to use a 
nosepoke to open the motorized door and access water bottles. In drinking session 
adaptation, doors could be opened with nosepoke during drinking sessions (10:00-12:00 and 
18:00-20:00) and remain closed during non-drinking sessions (20:00-10:00 and 12:00-18:00). 
Upon completion of the 3 habituation paradigms, 4 paradigms were used to assess cognitive 
aspects including spatial learning (place learning and place reversal), reward-driven 
behavior (sucrose preference) and avoidance learning and retention (avoidance 
conditioning).  
Figure 2.1: Habituation and cognitive testing paradigms in IntelliCage.     
 
2.3.6. Statistical analysis 
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a. Sickness behavior monitoring 
Results are expressed as mean (SD). Data processing and statistical analysis was 
performed using SPSS Statistics version 24 (IBM Corp., USA) and Python 2.7.10 (Python 
Software Foundation).  
b. Behavioral testing 
Data was analyzed with PyMice (Dzik et al., 2018), Python 2.7.10 (Python Software 
Foundation) and SPSS Statistics version 25 (IBM Corp., USA). Shapiro-Wilk test was used 
to examine the normality of data. For normally distributed samples, T test was used. Mann 
Whitney U test was used when the samples deviated from normal distribution. One-way 
ANOVA with Tukey’s procedure to correct for multiple comparisons was used for 
comparisons across three groups. For samples that deviated from normal distribution, 
Kruskal-Wallis test was used. Results were reported as mean ± standard error of mean 
(SEM). P-values < 0.05 were considered statistically significant. 
 
2.4. Sub-project 2: Refinement of humane endpoints in animal models of acute 
disease 
2.4.1. Animals 
All data analyzed were sourced from previous results and no animals were used in this sub-
project. Data from 922 animals were included. For the stroke model, 487 animals (Table 2.2) 
were used and randomly assigned to treatment groups at the age of 8 - 12 weeks. Mice were 
housed in groups of up to 12 at a room temperature of 22 ± 2°C with a humidity of 55 ± 10%. 
A 12:12h light/dark cycle with lights on at 7:00 was used (dark phase: 7:00-19:00; light phase: 
19:00-7:00). Aspen woodchips were used as bedding. For the sepsis model, see Section 
2.3.1. 
Strain n Origin 
C57BL/6NCrl 74 (m: 74) Charles River Laboratories 
Tg(Gjb6-cre/ERT2)53-33Fwp [MGI:4420273] 
x custom-made Tg(ROSA26-FLEX IL6)1Ch 
166 (m: 85;  
f: 81) 
F. Pfrieger; Charité Universitätsmedizin Berlin; 
Research Institutes for Experimental Medicine 
C57BL/6N-
Zfp580tm1a(EUCOMM)Hmgu/BayMmucd 
158 (m: 84;  
f: 74) 
Charité Universitätsmedizin Berlin; Research 
Institutes for Experimental Medicine 
Tg(Cdh5-cre/ERT2)1Rha x custom-made 
Tg(ROSA26-FLEX IL6)1Ch 
33 (m: 16;  
f: 17) 
R. Adams; Charité Universitätsmedizin Berlin; 
Research Institutes for Experimental Medicine 
Sorcs2tm1Anyk [MGI:5649357] 56 (m: 56)  




In the stroke model, Mice were subjected to 30 or 45 minutes temporary filamentous middle 
cerebral artery occlusion (MCAo) or sham procedure. The filamentous MCAo model was 
performed as described in Dirnagl et al. (2012). For sham animals, the filament was 
advanced to the MCA and withdrawn immediately. For the sepsis model, see Section 2.3.2. 
 
2.4.3. Physiological monitoring 
In the stroke model, body weight and a modified version of the DeSimoni neuroscore were 
obtained. Core body temperature was quantified non-invasively using subcutaneous RFID 
transponders as described in Donath et al. (2016). For the sepsis model, see Section 2.3.4.a-
e. 
 
2.4.4. Humane endpoint 
In the stroke model, animals were euthanized by cervical dislocation upon reaching a score 
of 2 of the 2nd criteria, or a score of 3 or 4 of the 3rd -12th criteria in the modified DeSimoni 
neuroscore (Donath et al., 2016). In addition, animals were euthanized when a loss > 20% 
baseline body weight occurred or the following signs were observed: complete paralysis with 
absence of spontaneous movement, severe ataxia or loss of postural reflexes, severe 
epileptic seizures, severe reduction of general health status with reduced grooming or refusal 
of food intake. For the sepsis model, see Section 2.3.4.f. 
 
2.5. Sub-project 3: Automatization of experiments with 8-arm radial maze 
2.5.1. Animals 
Twelve female homozygous wildtype C57BL/6J mice were derived from Charles River at 6-
8 weeks of age and housed locally. Two animals were excluded prior to the beginning of the 
experiment due to a dislodged/malfunctioning RFID transponder (n = 1) or death from a 
natural cause (n = 1). Mice were housed under standard animal laboratory conditions and 
transponder-implanted as in sub-project 1. Ten animals were subjected to the working 
memory paradigm and combined working/reference memory paradigm at the age of 18 
months. Of those, four randomly selected animals had been subjected to the working 
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memory paradigm once at the age of 9 months to ensure general functionality of the 
automated 8-arm RAM during its development. 
 
2.5.2. Experimental apparatus 
a. Automated 8-arm RAM 
The custom-made automated RAM (PhenoSys GmbH, Berlin, Germany) was constructed of 
eight transparent plastic tubes (diameter: 4.8 cm; length: 50 cm) radiating outwards from an 
octagonal central platform (span: 23.5 cm; side length: 9.7 cm; height: 12 cm; Figure 2.2, a). 
A plastic panel was placed on the central platform to allow for additional tactile cues and its 
orientation remained unchanged during the experiment (Figure 2.2, b). The central platform 
was covered with a transparent lid to prevent animals from escaping.  
Figure 2.2: Setup of the automated RAM. (a). Top view of the main body of the automated RAM. 
Arrow, position of the infrared sensors. (b). Plastic panel of tactile cues to be placed on the central 
platform of the RAM. (c). Automated sugar pellet dispenser. (d). RFID transponder-based ID sorter 
and climbing wire connecting the homecage and the RAM. 
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An automated sugar pellet dispenser was located at the end of each arm (Figure 2.2, c). 
Upon first entry to a baited arm, an animal was detected by the infrared sensor, which 
triggered one sugar pellet (Purified Rodent Tablets 5TUL, Test Diet, Richmond, IN, USA) to 
be dispensed. No sugar pellet was dispensed in an un-baited arm. When all baited arms 
have been visited and an animal has returned to the central platform, mechanical doors at 
the entrance of radial arms are closed to prevent further entries.   
To allow animals to enter the automated RAM, a sorter (IDsorter, PhenoSys GmbH, 
Berlin, Germany; Figure 2.2, d) was placed between the homecage and the RAM. The sorter 
read an animal’s RFID transponder and granted 24/7 access to the maze as long as an 
animal’s ID was registered in the experiment’s configuration file and there was no other 
animal inside the maze. The homecage and sorting device were both placed below a plastic 
lab table (dimensions: 160 x 160 cm); the RAM was placed on top (81 cm above floor level). 
A wire-mesh climbing tube runs through a hole located in the middle of the tabletop, 
connecting the sorter with the central platform of the RAM, allowing animals to climb up to 
the RAM (Figure 2.2, d). In addition to the intra-maze tactile cues, extra-maze visual cues 













Figure 2.3: Custom-made cage for habituation. (a). Front view. (b). Top view. 
 
b. Custom-made cage for habituation 
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For familiarization, mice were house in a polycarbonate cage (dimensions: 42.5 x 27.6 x 15.3 
cm; 1290D Eurostandard Type III, Techniplast, Italy) with a custom-made lid (Figure 2.3). A 
borehole (diameter: 1cm) on the upper rim of the plastic tube allowed for sugar pellets to be 
placed for habituation purposes.  
c. Software 
The software controlling the RAM (PhenoSys GmbH, Berlin, Germany) allows data on 
behavioral event, component that registered the event (e.g., dispenser, door, infrared sensor, 
RFID reader) and duration of the event to be recorded. Data was exported for offline analysis 
after each experiment. Mechanical components of the RAM could be controlled and 
inspected through the software. 
 
2.5.3. Experiments 
Experiments with the RAM included three phases: habituation (3 days), working memory 
paradigm (7 days), and combined working/reference memory paradigm (5 days). During 
working memory paradigm and combined working/reference memory paradigm, animals 
could voluntarily access the automated RAM at any time. 
• Habituation: Animals were housed in the custom-made cage (Figure 2.3) to be 
familiarized with sugar pellets, which served as positive rewards during RAM experiments, 
and the wire-mesh climbing tunnel. Sugar pellets were placed inside the climbing piece of 
the custom-made cage daily at 9:00. Following habituation, mice were manually transferred 
to their homecage and were housed for the remainder of the experiment. 
• Working memory paradigm: An animal’s first entry into each radial arm triggered one 
sugar pellet to be dispensed at the end of the arm. The animal was able to collect a maximum 
of 8 sugar pellets before the end of each session.   
• Combined working/reference memory paradigm: Sugar pellets were dispensed upon 
the first entry into the 4 randomly chosen baited arms. The animal was able to collect a 
maximum of 4 sugar pellets before the end of each session. 
 
2.5.4. Exclusion criteria  
Data entries displaying one or more of the following errors were excluded from further 
analysis: (a). Malfunctioning pellet dispenser that did not dispense a sugar pellet upon an 
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animal’s first entry into a baited arm, (b). Incorrect registration of re-entries into visited arms 
by the infrared sensor, and (c). Incorrect registration of a session’s duration or paradigm-
related information. 
 
2.5.5. Statistical analysis 
Data are shown in mean ± standard error of mean (SEM). A Python script (Python 2.7.15, 
Python Software Foundation) was used to automatically process raw data files and calculate 
all parameter values. Processed data was analyzed and plotted with GraphPad Prism 
software version 8.0.0 (GraphPad Prism Software, San Diego, CA). To assess the effect of 
time, one-way repeated measures ANOVA was used and corrected for sphericity using the 
Greenhouse-Geisser correction when the assumption of sphericity was violated.  P-values < 






















3.1. Sub-project 1: Assessment of physiological and cognitive alterations in the 
mouse model of sepsis, and the effect of phagocytic deficiency or inhibition of 
phagocytic signaling pathways on cognitive functions 
3.1.1. Mortality 
Two-hundred and fifty-four out of 284 LPS-treated animals (89.4%) reached the pre-defined 
experimental endpoint. Eighteen of the 30 dead animals were found dead and 12 were 
euthanized upon reaching pre-defined humane endpoint. Death occurred 24-192 hours after 
the 1st injection (mean = 60.5 (35.1) hours). All saline-injected mice reached the pre-defined 
experimental endpoint. To facilitate comparison, animals were divided into three groups:  
1. Control (n = 151): treated with saline; reached the planned experimental endpoint; 
2. Survivor (n = 254): treated with LPS; reached the planned experimental endpoint;  
3. Non-survivor (n = 30): spontaneously died or were euthanized during sickness 
behavior monitoring. 
 
3.1.2. Post-treatment physiological changes in saline- and LPS-injected animals 
a. Core and surface temperatures 
No significant decrease in core and surface temperatures from baseline was observed in 
control animals (Figure 3.1, a, b). Survivor and non-survivor groups showed decreased core 
and surface body temperatures during the days of LPS injections. In the survivor group, 
lowest core temperature of both injection days was observed 12 hours following injection 
(day 1: 34.1 (2.3) °C; day 2: 35.3 (2.1) °C). In the non-survivor group, lowest core 
temperature was observed 12 (31.2 (2.3) °C) and 7.5 (25.4 (4.5) °C) hours following LPS 
injection on injection day 1 and 2.  
In the survivor group, lowest surface temperature of both injection days was observed 
12 hours following injection (day 1: 27.8 (1.9) °C; day 2: 28.4 (1.9) °C). Surface body 
temperature of the survivor group returned to baseline level within 96 hours following the 1st 
injection. Surface temperature of non-survivor animals was the lowest 12 and 9 hours 
following injection on injection day 1 and 2 (25.7 (1.8) °C and 23.7 (1.8) °C). 
b. Sickness severity score 
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Sickness severity score of control animals remained unchanged (Figure 3.1, c). Sickness 
severity score of the survivor group peaked 12 hours following injections on both day 1 and 
2 (1.2 (0.9)) and (1.4 (0.9)) and returned to baseline level within 96 hours following the 1st 
injection. Sickness score of non-survivors was at the daily maximum 12 hours after each 
injection (day1: 2.1 (0.7); day 2: 3.2 (0.7)). 
Figure 3.1: Physiological changes in LPS- and saline-injected animals during sickness behavior 
monitoring. (a). Core temperature. (b). Surface temperature. (c). Sickness severity score. (d). Body 
weight. Red arrow, time of LPS/saline injections. Data are presented as mean ± SEM. 
 
c. Body weight 
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No weight changes were observed in the control group (Figure 3.1, d). Body weight of the 
survivor group reached its minimum 54 hours following the 1st injection (17.7 (1.5) g) and 
returned to baseline level 168 hours following the 1st injection. Lowest weight of non-survivor 
animals was observed 96 hours after the 1st injection (14.4 (2.8) g). 
d. Activity level and nest building behavior 
All groups displayed comparable baseline activity and novelty-induced high ambulation level 
(Figure 3.2). A day-night rhythm was observed in control animals. Sustained decrease in the 
level of activity was observed from the 1st injection day until the end of video recording in 
survivor and non-survivor groups. A rebound in ambulation distance and percentage of 
activity was observed in the survivor group 48 hours after the 1st injection, but not in the non-
survivor group.  
Figure 3.2: Activity level of LPS- and saline-injected animals during sickness behavior monitoring. 
(a). Distance of ambulation. (b). Percentage of activity. Red arrow, time of LPS/saline injections. Data 
are plotted in 4-hour bins and presented as mean ± SEM. 
 
Nest building was comparable across groups at baseline. Both non-survivor group 
and survivor group displayed a decrease in nest building score after LPS injections, followed 




Figure 3.3: Nest building score of LPS- and saline-injected wildtype mice during habituation. Red 
arrow, time of LPS/saline injections. Data are presented as mean ± SEM. 
 
3.1.3. Cognitive alterations in LPS-injected mice and the effect of inhibition of 
microglial phagocytosis  
a. Saline- and LPS-injected wildtype mice 
Habituation: During free exploration, both groups displayed higher level of activity in the 
dark phase (Figure 3.4, a-c). LPS-injected mice had more visits, nosepokes and licks (p = 
0.003, 0.007 and 0.001, respectively) during the dark phase of the 1st day of free exploration. 
Saline- and LPS-injected mice required comparable amount of time to achieve 50 nosepokes 
in nosepoke adaptation (p = 0.054; Figure 3.4, d). 
Figure 3.4: Activity of LPS- and saline-injected wildtype mice during habituation. (a-c). Free 
exploration. (d). Nosepoke adaptation. Data are plotted in 4-hour bins for free exploration and 
presented as mean ± SEM. 
 
Cognitive tests: 
Place learning: Saline-injected mice had higher percentage of nosepokes at the water-
rewarded corner (“correct nosepokes”) in the 4-day place learning paradigm (p = 0.009; 
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Figure 3.5, a), and in the first 100 (p < 0.001; Figure 3.5, c) and 150 nosepokes (p = 0.03; 
Figure 3.5, d). 
Place reversal: LPS- and saline-injected mice had comparable percentage of correct 
nosepokes in the 4-day place reversal paradigm (p = 0.197; Figure 3.5, e). Saline-injected 
mice had higher percentage of correct nosepokes in the first 50, 100 and 150 nosepokes (p 
= 0.002, 0.004 and 0.003; Figure 3.5, f-h). 
Sucrose preference: Increase in preference towards sucrose-rewarded bottles was 
comparable across treatments (p = 0.087; Figure 3.6, a). 
Avoidance conditioning: Avoidance towards the previously air-puffing corner was 
comparable across treatments during training (p = 0.158; Figure 3.6, b). Higher avoidance 
retention was observed in saline-injected mice during test and re-test (p = 0.017 and 0.001). 
 
Figure 3.5: Spatial learning of LPS- and saline-injected wildtype mice. (a). Percentage of correct 
nosepokes in the 4-day place learning paradigm. (b-d). Percentage of correct nosepokes in the first 
50, 100 and 150 nosepokes of place learning. (e). Percentage of correct nosepokes in the 4-day 
place reversal paradigm. (f-h). Percentage of correct nosepokes in the first 50, 100 and 150 




Figure 3.6: Reward-driven behavior, avoidance conditioning and retention of LPS- and saline-
injected wildtype mice. (a). Change in preference towards sucrose-rewarded bottles. (b). Number of 
nosepokes at the air-puffing corner at baseline, during training (air-puffing phase), test and re-test 
(retention phase). Data are presented as mean ± SEM; *p < 0.05, **p < 0.01. 
 
b. LPS-injected wildtype and knockout mice 
Habituation: 
• Mertk: During free exploration, animals displayed higher activity level in the dark 
phase (Figure 3.7, a-c). A decrease in behavioral events but licks was observed in both 
groups after the 1st day of free exploration. Wildtype mice had more visits and nosepokes 
than knockout mice in the dark phase of day 1 of free exploration (p = 0.003 and 0.045). 
• Cd11b: For free exploration, data were not available due to mechanical errors. 
Knockout mice required less time to achieve 50 nosepoke (p = 0.031; Figure 3.7, d). 
• Mfge8: During free exploration, animals showed higher activity level in the dark phase 
(Figure 3.7, a-c). The number of visits, nosepokes and licks was comparable across 
genotypes (p = 0.351, 0.098 and 0.635, respectively).  
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Figure 3.7: Activity of LPS-injected wildtype and knockout mice during habituation. (a-c). Number 
of visits, nosepokes and licks in free exploration, (d). Time required to reach 50 nosepokes during 
nosepoke adaptation. Data are plotted in 4-hour bins for free exploration and presented as mean ± 




• Mertk: LPS-injected wildtype and knockout mice had comparable percentage of 
correct nosepokes in the 4-day place learning paradigm (p = 0.222; Figure 3.8, a) and in the 
first 50, 100 and 150 nosepokes (p = 0.650, 0.636 and 0.522, respectively; Figure 3.8, b-d). 
• Cd11b: Percentage of correct nosepokes during place learning and in the first 50, 100 
and 150 nosepokes was not significantly different across genotypes (p = 0.732, 0.990, 0.665 
and 0.711, respectively; Figure 3.8, a-d). 
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• Mfge8: In the 4-day place learning paradigm, wildtype mice showed higher 
percentage of correct nosepokes (p = 0.017). Wildtype and knockout mice displayed 
comparable percentage of correct nosepokes in the first 50, 100 and 150 nosepokes (p = 
0.347, 0.412 and 0.434, respectively; Figure 3.8, b-d).  
Figure 3.8: Spatial learning of LPS-injected wildtype and knockout mice. (a). Percentage of correct 
nosepokes in the 4-day place learning paradigm. (b-d). Percentage of correct nosepokes in the first 
50, 100 and 150 nosepokes of place learning. (e). Percentage of correct nosepokes in the 4-day 
place reversal paradigm. (f-h). Percentage of correct nosepokes in the first 50, 100 and 150 
nosepokes of place reversal.  Data are presented as mean ± SEM; *p < 0.05. 
 
Place reversal: 
• Mertk: Percentage of nosepokes at the water-awarded corner was comparable across 
genotypes in the place reversal paradigm (p = 0.689; Figure 3.8, e). In the first 50 and 150 
nosepokes, knockout mice showed higher percentage of correct nosepokes (p = 0.02 and 
0.022; Figure 3.8, f, h).  
• Cd11b: Percentage of correct nosepokes was comparable across genotypes in the 
place reversal paradigm and in the first 50, 100 and 150 nosepokes (p = 0.559, 0.162, 0.192 
and 0.441, respectively; Figure 3.8, e-h).   
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• Mfge8: Percentage of correct nosepokes was comparable across genotypes in the 
place reversal paradigm and in the first 50, 100 and 150 nosepokes (p = 0.078, 0.296, 0.553 
and 0.53; Figure 3.8, e-h).   
Sucrose preference: The degree of increase in preference towards sucrose-rewarded bottles 
was comparable across genotypes in Mertk and Cd11b mice (p = 0.829 and 0.118; Figure 
3.9, a). Increase in preference towards sucrose-rewarded bottles was higher in wildtype 
Mfge8 mice (p = 0.011; Figure 3.9, a).  
Avoidance conditioning: 
• Mertk: The two groups displayed comparable numbers of nosepokes at the air-puffing 
corner during training, test and re-test (p = 0.264, 0.787 and 0.698; Figure 3.9, b). 
• Cd11b: Number of nosepokes at the air-puffing corner was comparable across 
genotypes during training, test and re-test (p = 0.057, 0.094 and 0.482; Figure 3.9, b). 
• Mfge8: The two genotypes displayed comparable number of nosepokes at the air-
puffing corner during training (p = 0.057). In test and re-test, knockout mice showed greater 
avoidance towards the air-puffing corner (p = 0.029 and 0.029; Figure 3.9, b). 
Figure 3.9: Reward-driven behavior, avoidance conditioning and retention of LPS-injected wildtype 
and knockout mice. (a). Change in preference towards sucrose-rewarded bottles. (b). Number of 
nosepokes at the air-puffing corner. Data are presented as mean ± SEM; *p < 0.05. 
 
c. LPS-injected untreated and peptide-treated mice 
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Habituation: During free exploration, mice displayed higher activity level in the dark phase 
(Figure 3.10, a-c). Number of visits differed across treatment groups (p = 0.017). Peptide 
treatments led to a significantly higher number of licks (p = 0.006; Figure 3.10, c). Cilengitide- 
and cRGD-treated mice displayed more licks than untreated mice (p = 0.001 and 0.028) and 
had comparable licks (p = 0.281). During nosepoke adaptation, the time required to achieve 
50 nosepokes was comparable across treatments (p = 0.127; Figure 3.10, d). 
Figure 3.10: Activity of Cilengitide-treated, cRGD-treated and untreated LPS-injected wildtype mice 
during habituation. (a-c). Free exploration. (d). Nosepoke adaptation. Data are plotted in 4-hour bins 
for free exploration and presented as mean ± SEM. 
 
Cognitive tests: 
Place learning: Untreated mice displayed higher percentage of correct nosepokes than 
Cilengitide- or cRGD-treated mice (p = 0.026 and 0.009; Figure 3.11, a). Cilengitide-treated 
mice showed higher percentage of correct nosepokes in the first 50, 100 and 150 nosepokes 
than cRGD-treated mice (p = 0.001, 0.028 and 0.023; Figure 3.11, b-d).  
Place reversal: Percentage of correct nosepokes was comparable across treatments in the 
4-day place reversal paradigm (p = 0.073; Figure 3.11, e) and in the first 50, 100 and 150 
nosepokes (p = 0.625, 0.687 and 0.312; Figure 3.11, f-h). 
Sucrose preference: Increase in licks at the sucrose-rewarded bottles differed across 
treatments (p = 0.001). Cilengitide- and cRGD-treated mice displayed greater increase in 
preference towards sucrose-rewarded bottles than untreated mice (p < 0.001 and 0.011; 
Figure 3.12, a).  
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Avoidance conditioning: During training, test and re-test, avoidance towards the air-puffing 
corner was comparable across treatments (p = 0.435, 0.184 and 0.308, respectively; Figure 
3.12, b). 
Figure 3.11: Spatial learning of Cilengitide-treated, cRGD-treated and untreated LPS-injected 
wildtype mice. (a). Percentage of correct nosepokes in the 4-day place learning paradigm. (b-d). 
Percentage of correct nosepokes in the first 50, 100 and 150 nosepokes of place learning. (e). 
Percentage of correct nosepokes in the 4-day place reversal paradigm. (f-h). Percentage of correct 
nosepokes in the first 50, 100 and 150 nosepokes of place reversal. Data are presented as mean ± 
SEM; *p < 0.05, **p < 0.01. 
 
Figure 3.12: Reward-driven behavior, avoidance conditioning and retention of Cilengitide-treated, 
cRGD-treated and untreated LPS-injected wildtype mice. (a). Change in preference towards sucrose-
rewarded bottles. (b). Number of nosepokes at the air-puffing corner. Data are presented as mean ± 
SEM; *p < 0.05, **p < 0.01, ***p < 0.001.  
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3.2. Sub-project 2: Refinement of humane endpoints in animal models of acute 
disease  
3.2.1. Death prediction with core and surface temperatures  
First, core and surface temperatures from transponder-implanted animals were used 
separately to train the prediction models to compare the accuracy of core and surface 
temperatures in the prediction of death (n = 160). Secondly, the best performing models were 
trained with data from all animals whose surface temperature measurements were available 
36 hours following the 1st injection (n = 372) to test the effects of increased size of the training 
data on model performance. 
At 36 hours after the 1st injection, death could be predicted with high accuracy both 
from core and surface temperatures (accuracy = 96.3% and 95.6% for core and surface 
temperatures, respectively; n = 160; number of dead animals = 13). Surface temperature 
data from 372 mice (number of dead animals: 28) led to further increase in accuracy to 96.5%.  
 
3.2.2. Accuracy of death prediction  
Death could be predicted with an accuracy of 93.2% (male) or 93.0% (female) in the model 
of stroke and 96.2% in the model of sepsis, with Gaussian Naïve Bayes (stroke model) or 
decision tree of depth 2 (sepsis model) (Table 3.1). 
In the stroke model, 13 out of 23 male mice that spontaneously died or reached pre-
defined humane endpoint could have been euthanized on the 3rd day post-MCAo (average 
time of death = 4.08 (1.07) days). Six out of 181 survived mice (3.3%) were falsely predicted 
to die. Four out of 10 female mice that spontaneously died or reached pre-defined humane 
endpoint could have been euthanized on the 2nd day post-MCAo (average time of death = 
4.25 (2.28) days). Three out of 77 survived mice (3.9%) were falsely predicted to die (Figure 
3.13, a, b). Death could not be predicted with sufficient accuracy until the 2nd (female mice) 
or 3rd (male mice) day post-MCAo (Table 3.1, a, b). 
In the sepsis model, 25 out of 28 animals could have been euthanized 24 hours post-
treatment (average time of death = 58.7 (35.0) hours). Six out of 254 survived mice (2.3%) 
were falsely predicted to die (Figure 3.13, c). Data obtained at 12 hours after the 1st injection 
could not be used to predict impending death reliably due to the low sensitivity, precision and 
accuracy (Table 3.1, c).  
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Figure 3.13: Using decision boundaries determined by machine learning models in death prediction. 
(a). Male mice, stroke model. (b). Female mice, stroke model. (c). Sepsis model. Blue dot, survived 
animal; red dot, animal euthanized upon reaching the pre-defined humane endpoint or died 
spontaneously; blue area, predicted survival; red area, predicted death. 
 
3.2.3. Using additional parameters in model training to improve performance 
In male mice of the stroke model, using weight change on the 1st day post-MCAo and core 
temperature change on the 3rd day post-MCAo as additional parameters increased sensitivity 
from 0.34 to 0.61, precision from 0.64 to 0.74, and accuracy from 0.91 to 0.93 (Table 3.1, a). 
In female mice, using neuroscore and core temperature change on the 2nd day post-MCAo 
in addition to weight change have improved sensitivity from 0.19 to 0.69, precision from 0.25 
to 0.83 and accuracy from 0.86 to 0.93 (Table 3.1, b).  
In the sepsis model, when the model was trained with data from 24 hours post-
treatment, sickness score as an additional parameter in model training increased sensitivity 
and accuracy by 0.22 and 0.01 (Table 3.1, c). No improvement in model performance was 
observed when sickness score was used as the additional parameter in model training for 
data from 36 hours post-treatment. 
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a. 
data male, stroke model 
physiological 
parameters 
used in model 
training 
weight change, 3rd day after 
treatment 
1. weight change, 1st day 
after treatment 
2. weight change, 2nd day 
after treatment 
3. core temperature change, 
2nd day after treatment 
1. weight change, 1st day 
after treatment 
2. weight change, 3rd day 
after treatment 
3. core temperature change, 
3rd day after treatment 
sensitivity  0.339 (0.148) 0.482 (0.081) 0.613 (0.088) 
precision 0.644 (0.274) 0.667 (0.272) 0.738 (0.070) 
accuracy 0.907 (0.026) 0.902 (0.046) 0.932 (0.018) 
averaged  0.630 0.684 0.761 
b.  
data female, stroke model 
physiological 
parameters 
used in model 
training 
weight change, 2nd day after 
treatment 
1. neuroscore, 1st day after 
treatment  
2. weight change, 1st day 
after treatment 
3. core temperature change, 
1st day after treatment 
1. neuroscore, 2nd day after 
treatment  
2. weight change, 2nd day 
after treatment 
3. core temperature change, 
2nd day after treatment 
sensitivity  0.194 (0.142) 0.361 (0.307) 0.694 (0.275) 
precision 0.25 (0.204) 0.417 (0.312) 0.833 (0.236) 
accuracy 0.863 (0.045) 0.896 (0.029) 0.930 (0.030) 
averaged  0.436 0.558 0.819 
c. 
data sepsis model, 12 hours 
after 1st treatment 
sepsis model, 24 hours after 
1st treatment 























































averaged  0.303 0.303 0.789 0.857 0.818 0.818 
Table 3.1: Death prediction with individual or combination of parameters at different time points. (a). 
Male mice, stroke model. (b). Female mice, stroke model. (c). Sepsis model. Data are shown as 
mean (SD). 
 
3.3. Sub-project 3: Automatization of experiments with 8-arm radial maze  
3.3.1. Entry to the RAM 
All animals entered the automated RAM during the experiment. The average latency to first 
RAM entry was 17h55 min ± 9h14 min. Seven out of 10 animals entered the automated RAM 
within the first 1h34 min after the start of the experiment. The average number of RAM visits 
was 8.81 ± 0.27 times per day during the working memory and 12.40 ± 0.49 times per day 
during the combined working/reference memory paradigms, respectively. The average 
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number of RAM visits per hour showed good agreement with the animals’ diurnal activity 
pattern (Figure 3.14).  
 
Figure 3.14: Average number of visits to the automated radial 8-arm maze by hour across all animals 
and experiments. Data are presented as mean ± SEM. 
 
3.3.2. Working memory paradigm  
The number of daily maze visits remained unchanged (F = 2.65, p = 0.11; Figure 3.15, a), 
while both the number of arm entries per session and the time needed to complete one 
session decreased (F = 6.89, p < 0.01 and F = 14.62, p < 0.001; Figure 3.15, b, c). The 
increase in the number of baited arm entries was not significant (F = 4.77, p = 0.05; Figure 
3.15, d) while the number of working memory errors decreased (F = 7.85; p < 0.001; Figure 
3.15, e). The ratio of the number of baited arm entries to total arm entries increased (F = 
10.11, p < 0.0001; Fig. 3.15, f). 
 
3.3.3. Combined working/reference memory paradigm 
The number of daily visits increased and the number of arm entries per session decreased 
(F = 16.13, p < 0.0001 and F = 4.92, p = 0.03; Figure 3.16, a, b), while the session duration 
remained unchanged (F = 0.76, p = 0.49; Figure 3.16, c). No increase was observed in the 
number of baited arms entered (F = 1.09, p = 0.33; Figure 3.16, d). There was no effect of 
time on working memory error (F = 2.02, p = 0.16; Figure 3.16, e). However, reference 
memory error and re-entries into un-baited arms decreased (F = 11.13, p < 0.001 and F = 
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4.06, p < 0.05; Figure 3.16, f, g). The number of baited arms entered in relation to total arm 
entries remained unchanged (F = 1.85, p = 0.19; Figure 3.16, h). 
 
Figure 3.15: Learning performance of mice tested with the automated RAM using a spatial working 
memory paradigm. Data are presented as mean ± SEM. 
 
 
Figure 3.16: Learning performance of mice tested with the automated RAM using a combined spatial 
working/reference memory paradigm. Data are presented as mean ± SEM. 
 
3.3.4. Spatial learning by activity phase 
The number of daily visits to the automated RAM was reduced during the light phase when 
compared to the dark phase (3.36 ± 0.24 vs 5.97 ± 0.24 and 3.04 ± 0.23 vs 9.74 ± 0.34 for 
working memory and combined working/reference memory paradigms, respectively; Figure 
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3.17, a and Figure 3.18, a). Due to the low number of visits, between and within-subject 
variation increased during the light phase when compared to the dark phase for working 
memory and combined working/reference memory paradigms, respectively (Fig. 3.17 and 
Fig. 3.18). However, despite these variations, there was good general agreement of learning 
performance between the two phases (Fig. 3.17 and Fig. 3.18). 
 
Figure 3.17: Learning performance of mice during the working memory paradigm by activity phase. 
Blue line, dark phase; red line, light phase. Data are presented as mean ± SEM. 
 
 
Figure 3.18: Learning performance of mice during the combined working/reference memory 





With the aim to understand how phagocytic deficiency or inhibition of phagocytic signaling 
pathways may affect cognitive functions, we have (a). Elicited sickness behavior in a mouse 
model of LPS-induced sepsis, (b). assessed the cognitive functions of mice deficient for 
Mertk, Cd11b or Mfge8, and (c). assessed the cognitive functions of mice treated with 
Cilengitide or cRGD. In addition, to maximize reproducibility of research and to minimize 
unnecessary suffering of animals, attempts have been made to automate an 8-arm radial 
arm maze for behavioral testing and to systematically determine humane endpoints for 
detecting animals at higher risk of death at earlier time points.  
Using a mouse model of sepsis, the current study showed improved performance in 
certain behavioral tasks in phagocytosis-deficient animals. In addition, we conducted 
experiments with the automated 8-arm RAM which required no food/water restriction or 
manual handling and observed good spatial working and reference memory in mice up to 18 
months of age. Lastly, machine learning-based endpoint determination has allowed for 
animals at higher risk of death to be identified at earlier time points. 
  
4.1. Lack of phagocytic proteins or treatment with Cilengitide or cRGD alleviated 
certain cognitive deficits 
In the present study, after a one-month recovery period, reduced activity was no longer 
present in LPS-inject mice. In alignment with previous research (Arai et al., 2001), LPS-
treated mice showed compromised performance in place learning and reversal, indicating 
impaired spatial learning. Another sign of cognitive deficits in LPS-treated mice was the 
higher preference towards the previously air-puffing corner in avoidance conditioning. Since 
LPS can decrease sucrose preference and induce long-term anhedonia-like behavior 
(Painsipp et al., 2011; Walker et al., 2018), it was unlikely that carry-over effects from the 
sucrose preference paradigm have caused more frequent nosepokes at the previously air-
puffing corner in LPS-injected animals. Therefore, a more plausible explanation of this 
phenomenon is LPS may impair avoidance retention. In summary, despite recovery in the 
level of activity from immediate sickness behavior, LPS-injected animals showed signs of 
long-term cognitive deficits in spatial learning and avoidance retention. 
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To our knowledge, this is the first study to assess long-term cognitive deficits in 
phagocytosis-deficient animals. Previous research has linked Mertk- or Mfge8-deficiency 
with reduced brain atrophy, improved neurological function and alleviated motor deficits 
(Neher et al., 2013). Thus, improved initial spatial learning in mice with Mertk-deficiency 
could potentially be explained by the prevention of neuronal/synaptic loss and therefore, 
preserved cognitive functions by Mertk-deficiency. In the meantime, Cilengitide-treated 
animals displayed improved spatial learning at the beginning of the place learning paradigm 
compared with animals treated with the inactive control peptide cRGD, which could 
potentially be attributed to inhibition of phagocytic signaling pathways.  
As Neher et al., (2013) have used a rodent model of focal brain ischemia and 
examined the motor functions of animals used in the study, it is unclear whether the same 
functional implications of Mertk- or Mfge8-deficiency would generalize to a mouse model of 
sepsis and non-motor tasks. This might be the reason why Mfge8 wildtype mice displayed 
efficient spatial learning despite poor avoidance retention. Although not within the scope of 
the PhD project, histological analysis is being performed to understand how 
neuronal/synaptic loss is impacted by specific phagocytic pathways. With this analysis, a 
deeper understanding of (a). the occurrence of neuronal/synaptic loss in brain regions 
including the hippocampus and frontal cortex following LPS and (b). whether the lack of 
phagocytic proteins modulates neuronal/synaptic loss in these regions and preserves 
neurons/synapses, could be achieved, giving rise to more comprehensive explanations of 
the behavioral data.  
   
4.2. Use of machine learning models in determination of humane endpoints  
Machine learning, a technique used to identify underlying patterns from given datasets that 
could be generalized to new data, has been applied in studies using animals (Kabra et al., 
2013; Han et al., 2018). With the aim to reduce animals’ stress and suffering and to maximize 
reproducibility of experimental results, we have examined the applicability of machine 
learning in determining humane endpoints.  
While traditional approaches in humane endpoint definition suffer from high degrees 
of heterogeneity which confounds identification of methods in endpoint determination that 
can be applied to more than one study (Mei et al., 2019), machine learning has enabled 
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identification of case-specific cut-off values across animal models without fundamental 
change in methodology. With models trained using body weight, sickness severity scores 
and surface or core temperature data, a significant percentage of animals at higher risk of 
death could have been euthanized at least one day earlier. To our knowledge, this is the first 
study using machine learning models to systematically determine humane endpoints in 
mouse models of acute disease and there is no previous data to compare our results to. 
Potential advantages of machine learning-based approach for the endpoint determination 
include improved standardization and comparability, as standardized metrics could be used 
across studies to evaluate model performance. Moreover, once a model is trained with 
sufficient data, it could be used repeatedly by researchers and animal technicians to 
determine whether an animal has an increased risk of death.  
 
4.3. Use of automated 8-arm radial maze in the study of spatial learning 
Attempts have been made to (a). automatize the recording of experiment-related events by 
using pellet sensors (Miyakawa et al., 2001), photo emitter/detector pairs (Peele and Baron, 
1988), and pressure detectors (Dubreuil et al., 2003) allowing for remote monitoring of an 
animals’ location and learning performance, (b). control mechanical parts of the RAM without 
requiring direct manual manipulation by using automated doors (Brillaud, Morillion and De 
Seze, 2005), and (c). facilitate data collection and visualization by automatically recording 
an animal’s reward intake (Miyakawa et al., 2001). However, to the best of our knowledge, 
none of the previous approaches allowed for the absence of a human experimenter and 
voluntary 24/7 entry of animals into the apparatus without requiring any food and/or water 
deprivation. In this study, with the custom-made habituation apparatus and the automated 
8-arm RAM, animals have voluntarily entered the RAM and achieved efficient spatial learning 
without food and/or water restriction. Automatization of the RAM was achieved on three 
levels: (a). handling-free habituation/experimental procedures, (b). online data collection and 
(c). offline data analysis.  
Mice could achieve efficient spatial learning within the first 3-4 days of both paradigms. 
In working memory paradigm, working memory error has decreased while the time for 
session completion has shortened. In combined working/reference memory paradigm, 
animals showed significant decrease in reference memory error and re-entries into un-baited 
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arms. In the working memory paradigm of Miyakawa et al., (2001) using a partially automated 
RAM, mice generally required more than 10 daily trials to achieve a revisiting error less than 
10, and the time that animals spent to collect 8 pellets was the shortest on the 13th day (~400 
seconds). In the present study, the time required to complete one session was 204.56 
seconds on day 7 with an average of 7.88 pellets collected per session. A possible 
explanation of the improved spatial learning performance of mice in the automated 24/7 
accessible RAM is the markedly increased daily visit frequency. Experiments in the 
automated RAM were carried out without the presence of experimenters, therefore, the 
automated RAM may improve standardization and comparability of results across studies by 
excluding potential experimenter effects and bias. 
 
4.4. Limitations, outlook and conclusions 
4.4.1. Sub-project 1: Assessment of physiological and cognitive alterations in the 
mouse model of sepsis, and the effect of phagocytic deficiency or inhibition of 
phagocytic signaling pathways on cognitive functions 
One of the limiting factors in sickness behavior monitoring was the proximity of the RFID 
transponder’s implantation site to brown adipose tissue located in the interscapular region, 
which is an important heat generator in mice and thus might have a confounding effect on 
core temperature readings (Mei et al., 2018). Secondly, due to transponder malfunction and 
technical errors during temperature acquisition, core temperature measurements from 22 
animals were partially or fully excluded from data analysis.  
As the large number of parameters in experiments with IntelliCage could be 
particularly challenging for interpretation and replication of experimental results, we have 
tried to avoid introducing novel parameters and primarily examined those frequently used in 
published studies. In the present experimental design, experimenter presence and manual 
handling were unavoidable during sucrose preference and avoidance conditioning, when 
sucrose solution was introduced, or animals were transported from and back to the 
homecage. This intervention, in combination with the presentation of aversive stimulus 
during avoidance conditioning, can introduce a source of bias, as mice have been housed in 
the IntelliCage for 2 weeks without direct contact with the experimenter. Secondly, the use 
of sucrose solution prior to paradigms involving aversive stimulus may confound the 
 48 
experimental results. Given these limitations, it would be desirable to re-arrange the 
experimental paradigms to optimize the protocol. For example, the sucrose preference 
paradigm could be conducted shortly after animals have been familiarized with IntelliCage, 
instead of by the end of the experiment, to minimize the confounding effects of sucrose-
induced hedonic behavior on avoidance conditioning. This way, drinking session adaptation 
and the spatial learning paradigms could be conducted between the sucrose preference 
paradigm and avoidance conditioning, introducing a period of 10 days to wash out the effect 
of sucrose preference. Thirdly, due to technical problems with genotyping, 7 animals (1 Mertk, 
6 Cd11b) were excluded from data analysis, which led to a small sample size and potential 
difficulties in identifying significant relationships. Furthermore, hardware malfunctions of the 
IntelliCage including delayed registration of nosepokes and licks had been a recurring issue 
during device testing, and it would be necessary to avoid the same technical problems in 
future studies. As mice brain tissue from the present study is still being examined, behavioral 
data will be re-interpreted with care when results from immunohistochemistry and 
synaptosome analysis are made available. It would be essential, however, to conduct future 
studies to further quantify the effects of phagocytic deficiency or inhibition of phagocytic 
signaling pathways on behavior and cognition.  
 
4.4.2. Sub-project 2: Refinement of humane endpoints in animal models of acute 
disease 
Although a machine learning model has been tested in the present study, the availability of 
data that could be used to train and validate the current model was limited, as few studies 
have made raw data available in open data repositories. Therefore, the current model is of 
low complexity and may not generalize well in studies of larger populations. A future step 
would be to make the model public and obtain data from laboratories that use the model, to 
train the model again based on datasets of larger-scale, and to test the generalizability of 
the present method in other disease models. 
 
4.4.3. Sub-project 3: Automatization of experiments with 8-arm radial maze 
Before being applied in future studies, limitations of the current automated RAM setup should 
be assessed carefully. In the present study, 4.19% of data entries were excluded due to 
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hardware or software malfunctions, indicating the need for further optimization of the 
automated RAM. Secondly, it was not possible to determine the number of pellets being 
eaten per session with the current setup. This issue could be addressed by adding sensors 
or video-based analysis tools to the automated RAM. Thirdly, 4 animals were used to 
examine the functionality of the RAM at 9 months of age and then tested again at 18 months, 
which might be a source of bias. In addition, the number of daily entries to the automated 
RAM was not limited and may have resulted in some animals occupying the automated RAM, 
potentially outperforming their littermates. Although no animal significantly outperformed 
their littermates in the present study, in future studies, a pre-defined cut-off value for the daily 




In the present study, phagocytic deficiency for Mertk, Cd11b or Mfge8 or treatments with 
peptides have led to improved cognitive performance in certain behavioral tasks. Improved 
performance in behavioral tasks by the lack of phagocytic proteins or inhibition of phagocytic 
signaling are strain- and treatment-specific. Machine learning-based humane endpoint 
determination, together with automated behavioral testing systems, may minimize suffering 
and discomfort for experimental animals and optimize the interpretability and reproducibility 
of experimental results. Taken together, results from the current study indicated that (a). 
inhibition of specific phagocytic pathways may be a potential therapeutic target to alleviate 
cognitive deficits following critical illness, (b). machine learning-based endpoint 
determination and a fully automated cognitive testing apparatus minimized unnecessary 
suffering and handling-induced stress in animal experiments. Nevertheless, cognitive data 
should be interpreted in combination with histological analysis, and it would be essential to 
conduct more studies to further quantify the effect of phagocytic deficiency on cognitive 
functions. Limitations of both machine learning-based endpoint determination and the fully 
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clear, predictable, and irreversible criteria, which can be used as 
a substitute for a more severe experimental outcome such as ex-
treme suffering or death. Systematic implementation of humane 
endpoints can prevent or reduce pain and/or suffering whilst still 
meeting experimental objectives (Nemzek et al., 2004). 
Thus, application of humane endpoints is a key component of 
UH¿QLQJVWXGLHVWRFRPSO\ZLWK5SULQFLSOHV,QPRGHOVRIDFXWH
disease, death may occur within hours following an experimental 
intervention, which requires both intensive follow-up and consis-
1  Introduction
,Q H[SHULPHQWDO PRXVH VWXGLHV DQ LPSRUWDQW FKDOOHQJH IRU UH-
searchers is to identify an endpoint by which the experiment shall 
be terminated in order to minimize unnecessary suffering of ani-
mals without compromising the quality of the experimental data. 
To systematically address this challenge, the concept of humane 
endpoints was introduced almost 20 years ago in Europe (OECD, 
2000). The application of humane endpoints describes the use of 
Research Article
Refining Humane Endpoints in Mouse Models of  
Disease by Systematic Review and  
Machine Learning-Based Endpoint Definition
Jie Mei1, Stefanie Banneke2, Janet Lips1,3,4, Melanie T. C. Kuffner1,4,5, Christian J. Hoffmann1,4,6,  
Ulrich Dirnagl1,3,4,7,8, Matthias Endres1,4,6,7,8, Christoph Harms1,3,4,6 and Julius V. Emmrich1,2,6 
1Department of Neurology and Department of Experimental Neurology, Neurocure Cluster of Excellence, Charité – Universitätsmedizin Berlin, corporate 
PHPEHURI)UHLH8QLYHUVLWlW%HUOLQ+XPEROGW8QLYHUVLWlW]X%HUOLQDQG%HUOLQ,QVWLWXWHRI+HDOWK%HUOLQ*HUPDQ\2*HUPDQ)HGHUDO,QVWLWXWHIRU5LVN
$VVHVVPHQW*HUPDQ&HQWHUIRUWKH3URWHFWLRQRI/DERUDWRU\$QLPDOV%I5%HUOLQ*HUPDQ\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Ideally, humane endpoints allow early termination of experiments by minimizing an animal’s discomfort, distress and 
pain while ensuring that scientific objectives are reached. Yet, lack of commonly agreed methodology and heterogeneity 
of cut-off values published in the literature remain a challenge to the accurate determination and application of humane 
endpoints.
With the aim to synthesize and appraise existing humane endpoint definitions for commonly used physiological param-
eters, we conducted a systematic review of mouse studies of acute and chronic disease models that used body weight, 
temperature and/or sickness scores for endpoint definition. We searched for studies in two electronic databases 
(MEDLINE/Pubmed and Embase). Out of 110 retrieved full-text manuscripts, 34 studies were included. We found large 
intra- and inter-model variance in humane endpoint determination and application due to varying animal models, lack of 
standardized experimental protocols, and heterogeneity of performance metrics (part 1).
We then used previously published and unpublished data on weight, temperature, and sickness scores from mouse 
models of sepsis and stroke and applied machine learning models to assess the usefulness of this method for parameter 
selection and endpoint definition across models. Machine learning models trained with physiological data and sickness 
severity score or modified DeSimoni neuroscore identified animals with a high risk of death at an early time point in both 
mouse models of stroke (male: 93.2% at 72 h post-treatment; female: 93.0% at 48 h post-treatment) and sepsis (96.2% at 
24 h post-treatment), thus demonstrating generalizability of endpoint determination across models (part 2). 
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution and reproduction in any medium, provi-
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databases for all research articles from 1946 to Feb 07, 2018 us-
ing the following Boolean string with Medical Subject Head-
ings (MeSH): ((“Mice”[Mesh]) AND (“Endpoint Determina-
WLRQ´>0HVK@25³$QLPDO8VH$OWHUQDWLYHV´>0HVK@25KXPDQH
HQGSRLQW25KXPDQH HQG SRLQW25 VXUURJDWH HQGSRLQW25




base database for all research articles from 1947 to Feb 07, 2018 
XVLQJ(0%$6(7KHVDXUXV(075((ZLWK%RROHDQVWULQJH[S
PLFHDQGH[S%RG\7HPSHUDWXUHRUH[S%RG\:HLJKWRUVFRUH




2.1.2  Exclusion and inclusion criteria
6WXGLHV WKDW IXO¿OOHG WKH IROORZLQJ LQFOXVLRQ FULWHULD ZHUH LQ-
cluded in the systematic review: (a) original research articles on 
mouse models of acute and/or chronic disease, (b) physiological 
parameters such as body temperature, body weight, or sickness 
severity scores were used individually or in combination to iden-
tify and/or evaluate humane endpoints, and (c) studies that ap-
SOLHGSUHGH¿QHGKXPDQHHQGSRLQWVGHWHUPLQHGIURPERG\WHP-
perature, body weight, or sickness severity scores. 
,UUHOHYDQWVWXGLHVZHUHH[FOXGHGLIDVXEMHFWVXVHGZHUHRWK-
er than mice, (b) article was a conference abstract, experimen-
tal protocol, or review, (c) article was written in a language oth-
er than English, (d) parameters used to determine humane end-
points were other than body temperature, body weight, or sick-
ness severity scores, and (e) no humane endpoints were applied 
in the course of experiments or if the study was unrelated to hu-
mane endpoint determination.
2.1.3  Extraction of relevant data
5HOHYDQWGDWDZDVH[WUDFWHGDQGFRPSDUHG WKURXJKDGDWD H[-
traction sheet. Extraction procedure was conducted by JM. Ex-
tracted data included (a) disease model, (b) sample size, (c) time 
course of the experiment, (d) frequency of evaluation/measure-
ment, (e) humane endpoint(s) used/proposed, (f) cut-off criteria 
for euthanasia, (g) metrics for evaluating the humane endpoint(s), 
DQG K SHUIRUPDQFH RI WKH KXPDQH HQGSRLQWV:KHQPXOWL-
ple endpoints were applied together in one study, all available 
descriptions were included. Missing data entries were marked 
with N/A (not applicable). 
2.2  Animal models of stroke and sepsis
2.2.1  Animals
1RDQLPDOVZHUHXVHGIRUWKLVVWXG\5DWKHUDOOGDWDDQDO\]HGLQ
this study were sourced from the authors’ previously published 




tency in endpoint determination. However, the varying nature of 
animal models and disease progression, lack of reporting these 
details in the literature, lack of standardized evaluation protocols, 
and heterogeneity of endpoints published in the literature make 
LWGLI¿FXOWWRDFFXUDWHO\GHWHUPLQHDQGDSSO\KXPDQHHQGSRLQWV
(Franco et al., 2012). 
So far, various approaches to humane endpoint evaluation have 
been proposed. These are based on physiological parameters such 
as body weight, temperature, or standardized sickness scores. 
Most commonly, analysis is conducted in a non-comprehensive 
manner, e.g., by arbitrary selection of a parameter and a cut-off 
value corresponding to the highest mortality rate or best separa-
tion between treated and sham-treated animals. However, these 
approaches often require manual, time-consuming computation 
and are prone to inter-observer bias. Machine learning, a tech-
nique used to identify underlying patterns from given datasets 
to produce reliable, repeatable predictions, has been applied in 
a number of different animal studies to classify individual/social 
EHKDYLRUV .DEUD HW DO  DXWRPDWL]H EHKDYLRU DQDO\VLV
(Han et al., 2018), or to identify behavioral strategies and deci-
sion-making processes (Yamaguchi et al., 2018). To our knowl-
edge, using machine learning methods for humane endpoint 
characterization has not yet been systematically assessed.
7KHDLPRI WKHSUHVHQWVWXG\WKHUHIRUHZDVWZRIROG¿UVW WR
LGHQWLI\ DQG DSSUDLVH H[LVWLQJ KXPDQH HQGSRLQW GH¿QLWLRQV LQ
mouse models of acute and chronic disease by conducting a sys-
tematic review of studies using weight, body temperature, and/or 
VLFNQHVVVFRUHVIRUKXPDQHHQGSRLQWUH¿QHPHQWDQGHYDOXDWLRQ
and second, to examine the potential usefulness and accuracy of 
using machine learning with an automated parameter search to 
DXWRPDWLFDOO\GH¿QHKXPDQHHQGSRLQWV7RPD[LPL]HJHQHUDOL]-
ability of results, we used previously published and unpublished 
data from two independent mouse models of acute disease, 





endpoints from the literature. However, we show that machine 
learning can be used to accurately determine humane endpoint 
criteria and cut-off threshold values at early time points follow-
LQJ VWURNH RU V\VWHPLF LQÀDPPDWLRQ WKXV SRWHQWLDOO\ UHGXFLQJ
otherwise unnecessary suffering.
2  Animals, materials, and methods
2.1  Systematic review
2.1.1  Search strategy
6WXGLHVZHUH LGHQWL¿HG VFUHHQHG DQG H[WUDFWHG IRU UHOHYDQW GD-
WD IROORZLQJ WKH 35,60$ 3UHIHUUHG 5HSRUWLQJ ,WHPV IRU 6\V-
WHPDWLF 5HYLHZV DQG 0HWD$QDO\VHV JXLGHOLQHV http://www. 
prisma-statement.org/LWHUDWXUHVHDUFKWLWOHDQGDEVWUDFWVFUHHQ-






























tal procedures were approved by the ethical review committee 





porting of results based on the authors’ own historical data com-
SOLHVZLWK WKH$55,9(JXLGHOLQHV .LONHQQ\HWDODQG
ZLWKWKHJXLGHOLQHVIRUJHQHWLFDOO\PRGL¿HGRUJDQLVPV
Data from 922 animals were included in this study. All inspec-
tions and measurements were performed in the same facility 
where animals were housed.




of natural causes or reached a humane endpoint prior to the start 




were housed in groups of up to 12 animals per cage at 22 ±2°C, 
humidity of 55 ±10%, and a 12-hour light/dark cycle (12:12 h, 
lights on: 7:00 h, lights off: 19:00 h). Aspen woodchips were used 
as bedding.
For the sepsis model, female homozygous knockout mice and 
their homozygous wildtype littermates were used in experiments 
DW WKH DJHRI ZHHNV WRWDO Q 7DE E0LFHZHUH
KRXVHGLQJURXSVRIXSWRDQLPDOVSHUFDJHDW &KX-
midity of 60 ± 5%, and a 12-hour light/dark cycle (12:12 h light/
dark cycle, lights on: 20:00, lights off: 8:00) and were exposed to 
white noise at moderate intensity (65dB) during the dark phase 
'RKP6OHHSPDWH0DUSDF6RXQG0DFKLQHV:LOPLQJWRQ86$




¿ODPHQWRXV PLGGOH FHUHEUDO DUWHU\ RFFOXVLRQ 0&$R RU VKDP 
SURFHGXUH7KH¿ODPHQWRXV0&$RPRGHOZDVSHUIRUPHGDVGH-
VFULEHG LQ'LUQDJOHWDO )RUVKDPDQLPDOV WKH¿ODPHQW




control, respectively. The injection was performed as previously 
described (Mei et al., 2018).
Animals were randomized to treatment groups using the 
*UDSK3DGFDOFXODWRUWRRO1RU5HVHDUFK5DQGRPL]HUWRRO2 for the 
stroke and sepsis model, respectively. To minimize experimenter 
bias, randomization was conducted by a researcher who was not 
7DE6WUDLQDQGRULJLQRIDQLPDOVXVHGIRUDXWRPDWHGSDUDPHWHUVHDUFKWRGHÀQHKXPDQHHQGSRLQWVIRU$PLGGOH 
cerebral artery occlusion (MCAo) stroke model, and (B) lipopolysaccharide (LPS)-induced sepsis model 
m, male; f, female
A 
Strain n Origin
C57BL/6NCrl 74 (m: 74) Charles River Laboratories
Tg(Gjb6-cre/ERT2)53-33Fwp [MGI:4420273] x custom- 166 (m: 85; f: 81)  F. Pfrieger; Charité Universitätsmedizin Berlin; Research 
made Tg(ROSA26-FLEX IL6)1Ch  Institutes for Experimental Medicine 
C57BL/6N-Zfp580tm1a(EUCOMM)Hmgu/BayMmucd 158 (m: 84; f: 74) Charité Universitätsmedizin Berlin; Research Institutes for  
  Experimental Medicine
Tg(Cdh5-cre/ERT2)1Rha x custom-made 33 (m: 16; f: 17) R. Adams; Charité Universitätsmedizin Berlin; Research 
Tg(ROSA26-FLEX IL6)1Ch  Institutes for Experimental Medicine
Sorcs2tm1Anyk [MGI:5649357] 56 (m: 56) 
B
Strain n Origin
C57BL/6J 55 (f) Charles River Laboratories
Mertk (B6;129-Mertktm1Grl/J ) 126 (f) The Jackson Laboratory
Cd11b (B6;129-Mertktm1Grl/J, B6.129S4-Itgamtm1Myd/J) 126 (f) Hertie Institute for Clinical Brain Research
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2.2.5  Humane endpoint criteria
,QWKHVWURNHPRGHODQLPDOVZHUHHXWKDQL]HGE\FHUYLFDOGLVORFD-
tion upon reaching a score of 2 of the 2nd criteria, or a score of 
RURIWKHrd-12thFULWHULDLQWKHPRGL¿HG'H6LPRQLQHXURVFRUH
'RQDWKHWDO,QDGGLWLRQWRWKHVFRUHEDVHGFULWHULDDQL-
mals were euthanized when a loss of more than 20% baseline body 
weight occurred or the following qualitative humane endpoint cri-
teria were observed during inspection: complete paralysis with ab-
sence of spontaneous movement, severe ataxia or loss of postur-
DO UHÀH[HVVHYHUHHSLOHSWLFVHL]XUHVVHYHUHUHGXFWLRQRIJHQHUDO
health status with reduced grooming or refusal of food intake. 
,Q WKH VHSVLVPRGHO XSRQ UHDFKLQJ D VLFNQHVV VFRUH JUHDWHU
than 4 once or a score of 4 twice within 2 hours, animals were im-
mediately removed from the cage and euthanized by cervical dis-
location (Mei et al., 2018).








sis, leading to exclusion of 41 out of 487 animals (8.4%).
,QWKHVHSVLVPRGHOQRDQLPDOZDVH[FOXGHG
2.2.7  Data analysis and statistics
5HVXOWVDUHH[SUHVVHGDVPHDQ6'XQOHVVRWKHUZLVHVSHFL¿HG'D-
WD SURFHVVLQJ DQG VWDWLVWLFDO DQDO\VLVZDV SHUIRUPHG XVLQJ 6366
YHUVLRQ  6366 ,QF &KLFDJR ,/ 86$ DQG 3\WKRQ  
3\WKRQ6RIWZDUH)RXQGDWLRQ%HDYHUWRQ2586$5LVNRIGHDWK
as an outcome event was evaluated with the scikit-learn toolkit 
VNOHDUQ3HGUHJRVDHWDOIRUSK\VLRORJLFDOSDUDPHWHUVLQFOXG-
ing core body temperature, surface body temperature, body weight 
DQGPRGL¿HG'H6LPRQLQHXURVFRUHRUVLFNQHVVVHYHULW\VFRUH
A primary aim of this study was to identify physiological pa-
rameters that can be used to separate animals that are at a high-
er risk of death from animals that would reach the planned ex-
perimental endpoint. Therefore, apart from assessing the predic-
WLRQDFFXUDF\RIYDULRXVPRGHOVZHDOVRLGHQWL¿HGWKHSUHGLFWLYH
power of physiological parameters, individually or in combina-
tion. To assess and identify (a) general performance of machine 
learning models, (b) usability of physiological parameters ob-
tained at different time points in death prediction, and (c) mod-
HOK\SHUSDUDPHWHUVJULGVHDUFKZLWKVWUDWL¿HGIROGFURVVYDO-
idation was applied. Core temperature (stroke model), surface 
temperature (sepsis model), body weight (both models), sickness 
VFRUH VHSVLVPRGHO RUPRGL¿HG'H6LPRQL QHXURVFRUH VWURNH
model), and the absolute change of these parameters per time-
point (calculated by subtracting the baseline value from the mea-
sured value at a given timepoint) were used individually or in 
combination to train machine learning models. Models used for 




formation on strain, genotype and treatment group assignment 
was concealed from experimenters until the end of the study.
 
2.2.3  Physiological parameters and scoring
,QWKHVWURNHPRGHOERG\ZHLJKWDQGDPRGL¿HGYHUVLRQRIWKH
DeSimoni neuroscore, a composite score of general behavior-
DODOWHUDWLRQVDQGIRFDOPRWRUVHQVRU\UHÀH[DQGEDODQFHGH¿-
cits to evaluate neurological outcome following cerebral isch-
emia in mice, were obtained as previously described (Donath et 
DO&RUHERG\WHPSHUDWXUHZDVTXDQWL¿HGQRQLQYDVLYHO\
XVLQJVXEFXWDQHRXVUDGLRIUHTXHQF\LGHQWL¿FDWLRQ5),'WUDQ-
sponders as described (Donath et al., 2016). 
,QWKHVHSVLVPRGHODVLFNQHVVVFRUHDGDSWHGIURPWKHPXULQH
sepsis score was obtained based on general activity and response 
to stimuli as previously described (Mei et al., 2018). Surface 
ERG\WHPSHUDWXUHZDVTXDQWL¿HGXVLQJWZRQRQFRQWDFWLQIUDUHG
thermometer models as described previously (Mei et al., 2018). 
)RUERG\ZHLJKWDFTXLVLWLRQDEHQFKVFDOH3&%.(51
	62+1*PE+%DOLQJHQ*HUPDQ\ZDVXVHG$QLPDOVZHUH
weighed once their body and tail were in a plastic box placed on 
the top of the scale. 
,QERWKGLVHDVHPRGHOVWKHGXUDWLRQRIPDQXDOKDQGOLQJZDV
minimized to reduce stress and discomfort when examining 
VLJQVRIVLFNQHVVRIH[SHULPHQWDODQLPDOV/RZDQ[LHW\KDQGOLQJ
methods including cupping the animal between both hands and 
XVLQJDKDQGOLQJER[ZHUHDSSOLHG,QDGGLWLRQDQGRQO\LIQHF-
essary, animals were lifted by the base of the tail for no longer 
WKDQVHFRQGV
2.2.4  Timeline of physiological monitoring
,QWKHVWURNHPRGHOEDVHOLQHERG\ZHLJKWDQGWHPSHUDWXUHZHUH
measured at 7:00-8:00 on the day of MCAo, followed by 2 in-
spections on the day of surgery and consequent daily inspection 
for qualitative humane endpoint criteria at 7:00-9:00 until day 28. 
7KHPRGL¿HG'H6LPRQLVFRUHIRULQGLYLGXDODQLPDOVZDVDVVHVVHG
on the day of MCAo and on the 1st, 2nd, 7th, 14th, and 21st day 
post-MCAo as previously described (Donath et al., 2016). 
,Q WKH VHSVLV PRGHO EDVHOLQH WHPSHUDWXUH DQG ZHLJKW ZHUH
PHDVXUHGDWRQWKHGD\RIWKH¿UVWLQMHFWLRQ%RG\WHPSHUD-
ture and sickness score were obtained eight times daily (8:00 to 
20:00, every 90 min) on the two consecutive injection days, then 
three times daily (8:00 to 20:00, every 6 h) for two days after the 
second injection, and once a day (8:00) from post-injection day 
XQWLOGD\DIWHUWKHVHFRQGLQMHFWLRQ%RG\ZHLJKWZDVRE-




body temperature, animals were weighed after body temperature 
acquisition. 
Body temperature, body weight, and sickness score were as-
VHVVHGIRURUGD\VSRVW0&$RRU/363%6LQMHFWLRQUH-
VSHFWLYHO\ ,QDFFRUGDQFHZLWK WKHDLPRI WKHVWXG\GDWD IURP
time points later than that of the death of the last animal in each 
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3  Results
3.1  Systematic review
VHDUFKUHVXOWVZHUHUHWULHYHG0HGOLQH(PEDVH
DQGZHUHLQFOXGHGLQWLWOHDQGDEVWUDFWVFUHHQLQJDIWHUGXSOL-
cates were removed. Overall, 110 full text articles were screened 

















Available data from all time points before the average time of 
death of non-survivor animals was included in the analysis. First, 
to reduce complexity of the analysis and enhance the applicabil-
ity of the method, measurements obtained at the same time point 
were used to train the predictive models. For example, tempera-
ture readings obtained at 24 hours after stroke/sepsis could be 
combined with sickness scores obtained at the same time point, 
but not sickness scores obtained at other time points. Second, 
an expanded parameter search with combinations of physiolog-
ical parameters obtained at different time points was conduct-
HG:KHQWUDLQLQJVXSSRUWYHFWRUPDFKLQHVLQSXWIHDWXUHVZHUH
scaled to a zero mean and unit variance. 
2.2.8  Data availability
Two datasets including (1) core body temperature, body weight, 
DQG PRGL¿HG 'H6LPRQL QHXURVFRUH RI DQLPDOV RI WKH VWURNH
model and (2) surface body temperature, body weight and sick-




Fig. 1: Flow 
diagram showing 
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Tab. 2: List of studies included in the review (n = 34) summarized by type of experiment, sample size, time course  
of the experiment, type of humane endpoints, frequency of inspection/measurement, and cut-off threshold used/proposed  
for euthanasia  
N/A, not found/not available; sur, survived
Experiment Sample size Time course Type of humane Frequency of Cut-off threshold Reference 
















































n = 122; 







n = 118; 
n(sur) = 93
n = 31; 
n(sur) = 10




n = 30; 
n(sur) = 19 
 
 
n = 45 
n = 40; 
n(sur) = 27 
 
 
n = 60 
 
n = 120; 





n = 118; 





n = 36 
 
 
n = 30 
 
 
n = 132; 
n(sur) = 77 
 
































































































every 12 h  
ÀUVWGD\V 
every 6 h (day 3 
and thereafter)
twice daily 
twice daily  




every 10-30 min 
ÀUVWKSRVW
injection);  
every 1-2 h (there-
after)
daily 





at 24 h and 30 min 
after application of 
analgesia
once daily (until 
day 4; day 15-30); 
twice daily  
(day 5 -day 15) 
 
 
twice daily  
(score 1);  
3 times/day  
(score 2);  
4-6 times/day 
(score 3);  
hourly (score 4)
5-7 times/week  
 
 
once a week; 





















< 32°C;  
clinical signs












core temperature  
< 34.5°C; > 0.05g/
day weight loss, 
combination of 
temperature and 
weight loss;  
score = 3 for 24 h






> 20% weight loss 
or > 15% weight 
loss for 72 h; 
clinical signs
> 15% weight loss; 
clinical signs 
 
score = 12  
 
 




Aldred et al., 2002 
 
 
Arranz-Solis et al., 
2015
Bast et al., 2004 








Chappell et al., 
2011




Faller et al., 2015 
 












Hunter et al., 2014 
 
 
Husmann et al., 
2015 
 






























Experiment Sample size Time course Type of humane Frequency of Cut-off threshold Reference 
















































n = 10 
n = 78 
 
n = 16 




n = 56 
n = 36; 
n(sur) = 10 
n = 240; 
n(sur) = 57  
 
n = 175; 
n(sur) = 66 
 
n = 34; 
n(sur) = 23 
n = 40 
 
n = 110 
 
n = 15 
 
n = 162 
n = 42 
n = 359  
 


























































weight, score  















































every 1 to 2 hours  
once daily 
 
once daily (days 
1-6 and 23-30);  
twice daily (days 
7-22) 
once daily (days 
1-6; 19-30;  
twice daily (days 
7-18)





at least once every 
4 weeks 





















no recovery from 
hypothermia by 
765 min
> 25% weight loss; 
VFRUH
tumor > 10 mm 
(12mm), > 15% 














score = 3 
score = 1 with 
clinical signs;  
score = 3 
ZHLJKWORVV
core temperature  
< 25°C; 
score = 5  
 




score = 2 combined 
with a weight loss 
RI
temperature  
< 35°C or T x BW 
< 60% of baseline 
values on day 7 
after infection;  
T x BW < 90% of 
baseline value on 
day 2 or day 5  
after infection;  
T x BW < 85% of 
baseline value  
on day 1 after 
infection 
Kort et al., 1998 
Leon et al., 2005 
 
Miller et al., 2013 




Molins et al., 2012 
Nemzek et al., 
2004 
Nunamaker et al., 
2013a 
 
Nunamaker et al., 
2013b 
 
Passman et al., 
2015 
Paster et al., 2009 
 
Ray et al., 2010 
 
Sand et al., 2015  
 
Solomon et al., 
2011
Stoica et al., 2016 
Takayama-Ito et al., 
2017 
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DO$OGUHGHWDO+XVPDQQHWDO,QWZRVWXG-
LHV$GDPVRQHWDO7UDPPHOODQG7RWKLQGLYLGXDO
physiological parameters were assessed at different time points. 
,QWKUHHVWXGLHVDQLPDOVZHUHLQVSHFWHGRQO\RQFHDIWHUWUHDWPHQW
7DND\DPD,WRHWDO6DQGHWDO)DOOHUHWDO





HW DO  5D\ HW DO  DQG VXUIDFH ERG\ WHPSHUDWXUH 
Q $GDPVRQHWDO%DVWHWDO1HP]HNHWDO
'HOODYDOOH HW DO  FRXOG EH XVHG WR UH¿QH WKH KX-
PDQHHQGSRLQW ,QRI WKHVWXGLHVRWKHUSK\VLRORJLFDOSD-
rameters were used in combination or independently as humane 
endpoint criteria, including clinical signs (Beyer et al., 2009), 
ZHLJKW+DQNHQVRQHWDO$GDPVRQHWDO1HP]HN




(29.7 (0.6) °C) for endpoints determined from surface tempera-
WXUH,QDGGLWLRQUHFRYHU\IURPK\SRWKHUPLD/HRQHWDO
or a temperature drop below the baseline mean temperature (Mo-
OLQVHWDOZHUHXVHGDVKXPDQHHQGSRLQWV:KLOHLQPRVW
studies, animals were humanely killed upon reaching the cut-off 
criterion at one single time point, Beyer et al. (2009) euthanized 
DQLPDOVZKHQWKHERG\WHPSHUDWXUHZDVORZHUWKDQ&LQWZR
consecutive inspections. 







er et al., 2014). All of these 14 studies included additional hu-
3.1.1  Time course of the study and frequency  
of monitoring








$GDPVRQHW DO .RFKHW DO 7UDPPHOO DQG
7RWK  1XQDPDNHU HW DO DE 1HP]HN HW DO 
'HOODYDOOH HW DO $OGUHGHW DO :DUQHW DO 
9ODFKHWDO$UUDQ]6ROLVHWDOEHWZHHQRQHPRQWK
DQGPRQWKVLQVWXGLHV0LOOHUHWDO)DOOHUHWDO




A great variance was observed in the frequency of evaluation 
intervals, with the most frequent data collection occurring once 
SHUPLQXWHXVLQJDQDXWRPDWHGV\VWHP/HRQHWDOZKLOH
the longest interval between inspections was once or at least once 
HYHU\ZHHNV5D\HWDO:HLVPDQQHWDO6RPH
authors used an inspection frequency of once per day (Miller, D. 
6HWDO0LOOHU$HWDO&KDSSHOOHWDO3DV-
WHUHWDO1HP]HNHWDOZKLOHRWKHUVXVHGYDU\LQJ





5-7 times per week (Hunter et al., 2014). As expected, in studies 
with faster disease progression, authors adjusted the evaluation 
schedule accordingly by increasing the frequency of monitor-







Experiment Sample size Time course Type of humane Frequency of Cut-off threshold Reference 
   endpoint measurement 










n = 48; 
n(sur) = 22
n = 160; 
n(sur) = 100 
 




















every 15 minutes 
WLPHVGDLO\
maximum of 
10 h between 
observations
19 times at 
irregular intervals  
 
at least twice daily 
core temperature  
< 23.4°C








Vlach et al., 2000 
Warn et al., 2003 
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cy. For example, the composite obtained by multiplying weight 
and body temperature yielded higher prediction accuracy than ap-
plying weight or body temperature cut-off criteria individually.
3.1.6  Evaluation of the humane endpoints
Twenty studies assessed the performance of humane endpoints. 
3UHGLFWDELOLW\ RI GHDWK DV DQ RXWFRPH HYHQW ZDV HYDOXDWHG E\
means of sensitivity (n = 6, min = 68%, max = 100%, mean (SD) 
  $GDPVRQHWDO+DQNHQVRQHWDO
7UDPPHOODQG7RWK'HOODYDOOHHWDO.RUWHWDO





et al., 2010), percentage/number of mice present with a particular 




iological changes observed in different treatment groups (n = 2, 
VLJQL¿FDQW GLIIHUHQFH REVHUYHG3DVWHU HW DO /HRQ HW DO
 SRVLWLYH SUHGLFWLYH YDOXH Q    1HP]HN HW DO
 IDOVH SRVLWLYH UDWH Q     7UDPPHOO DQG 7RWK
2011), and corresponding mortality rate (n = 2, 86.2-100% and 
1XQDPDNHUHWDODEZLWKVRPHVWXGLHVXVLQJ
PXOWLSOHHYDOXDWLRQPHWULFV,QRQHVWXG\VSHFL¿FLW\ZDVXVHGWR
assess humane endpoint performance. However, it could not be 
appropriately assessed as none of the animals reached the pre-de-
¿QHGFXWRIIFULWHULRQ'HOODYDOOHHWDO
3.2  Death prediction in animal 
models of stroke and sepsis
To facilitate direct comparison, animals in both stroke and sep-
sis models were divided into three groups based on treatment and 
VXUYLYDO*URXSFRQWUROQVWURNH QVHSVLV FRQ-
sisted of sham animals or animals treated with saline that reached 
the planned experimental endpoint, group 2 (survivor group, 




nized upon reaching the humane endpoint criteria.
3.2.1  Body temperature in survivor and  
non-survivor animals
,QWKHVWURNHPRGHOWKHWHPSHUDWXUHRIWKHVXUYLYRUDQGQRQVXU-
vivor groups decreased by an average of 1.1°C and 4.6°C from 
EDVHOLQH&DQG&UHVSHFWLYHO\GXULQJ
WKH ¿UVW  GD\V IROORZLQJ 0&$R 7DE  7KH FRUH ERG\ 
temperature of the control group remained unchanged during the 
experiment.
,QWKHVHSVLVPRGHO/36WUHDWHGDQLPDOVVKRZHGDSURQRXQFHG
decrease in surface body temperature during the two consecutive 
LQMHFWLRQGD\VUHJDUGOHVVRIVXUYLYDOVWDWXV/RZHVWVXUIDFHWHP-
perature of survivor animals was observed 10.5 hours following 




DO 7DND\DPD,WR HW DO  ERG\ WHPSHUDWXUH +DQ-
NHQVRQHWDO$GDPVRQHWDO1HP]HNHWDO
and the product of body temperature and weight (Trammell and 
7RWK5D\HWDO$OWKRXJKDZHLJKW ORVVRIPRUH










days and was therefore considered as an indicator of higher risk 
RIGHDWK1HP]HNHWDO2QHVWXG\GLGQRWGH¿QHDFXW
off threshold for a weight-based humane endpoint (Faller et al., 
2015). Another used the product of body temperature and weight 
IRUKXPDQHHQGSRLQWGH¿QLWLRQ7UDPPHOODQG7RWK
3.1.4  Sickness severity score 
Among 15 studies that used sickness severity scores to deter-








al., 2009). There was great heterogeneity in score-based thresh-
ROGVUHÀHFWLQJWKHFRPPRQXVHRIPRGHOVSHFL¿FVFRUHV,Q
VWXGLHVKLJKHU VFRUHV LQGLFDWHGPRUH VHYHUH V\PSWRPV ,QRQH
study, a score of 0-1 was assigned to animals showing abnormal 
behavior and appearance, using a total score of 1 as the humane 
HQGSRLQW3DVWHUHWDO,QRQHVWXG\DVFRUHVKHHWLQGLFDW-
ing clinical symptoms was used to determine sickness severity, 
however, the cut-off value for early euthanasia was not clearly 
described (Aldred et al., 2002). 
3.1.5  Combining body weight, body 
temperature, and sickness severity scores 
in humane endpoint determination
,QVWXGLHVPRUHWKDQRQHSK\VLRORJLFDORUEHKDYLRUDOSDUDPH-
ter was used in determining the humane endpoint. Thus, the cut-
RIIFULWHULRQZDVGH¿QHGE\IXO¿OOLQJRQHRUPRUHSK\VLRORJLFDO
RUEHKDYLRUDOFULWHULD$PRQJWKHVWXGLHVVWXGLHVLQYROYHGD
direct combination (e.g., the product of two parameters) of more 
than one physiological parameter to derive a surrogate indicator 
IRUDKLJKHUULVNRIGHDWK+DQNHQVRQHWDO7UDPPHOODQG
7RWK5D\HWDO,QVWXGLHVXVLQJDSURGXFWRIPRUH
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4th day following MCAo. Once the minimum was reached, all 
groups subsequently recovered body weight until the end of the 
observation period. 
,QWKHVHSVLVPRGHOQRZHLJKWFKDQJHVRWKHUWKDQUDQGRPÀXF-
tuations were observed in control animals. Body weight of the sur-
YLYRUJURXSUHDFKHGLWVPLQLPXPKRXUVIROORZLQJWKH¿UVW/36
injection (17.7 (1.5) g) and returned to baseline at 192 hours (21.7 
(1.6) g, as compared to baseline weight = 21.5 (1.8) g). The low-
est weight of non-survivor animals (baseline weight: 21.4 (2.0) g) 
ZDVPHDVXUHGKRXUVDIWHUWKH¿UVWLQMHFWLRQJ




day after MCAo and subsequently decreased on the 2nd day af-
WHU0&$R7DE1RQVXUYLYRUVKDGDKLJKHUVFRUHRQWKHst 
and 2nd day following MCAo than survivors (16.0 (9.6) and 14.8 
(9.4) vs. 9.2 (5.2) and 9.1 (5.7), respectively). 
ERWKWKH¿UVWDQGVHFRQGLQMHFWLRQV&DQG& 
respectively). The surface body temperature of the survivor 
group returned to baseline within 96 hours following the second 
/36LQMHFWLRQ6XUIDFHWHPSHUDWXUHRIQRQVXUYLYRUDQLPDOVZDV
WKHORZHVWKRXUVIROORZLQJWKH¿UVWLQMHFWLRQ&
DQGKRXUV IROORZLQJ WKHVHFRQG LQMHFWLRQ   & UH-
VSHFWLYHO\1RVLJQL¿FDQWGHFUHDVHLQFRUHDQGVXUIDFHWHPSHUD-
tures from baseline was observed in control animals. 
3.2.2  Body weight in survivor and non-survivor  
animals
,Q WKH VWURNHPRGHO D GHFUHDVH LQ ERG\ZHLJKWZDV REVHUYHG
LQFRQWURODQLPDOVVXUYLYRUVDQGQRQVXUYLYRUV7DE,QWKH
FRQWUROJURXSERG\ZHLJKWZDVJDWEDVHOLQHGHFUHDV-
LQJWRDPLQLPXPRIJRQWKHnd day post-treatment. 
The lowest weight of survivor animals 21.0 (2.8) g was mea-
sured on the 2nd day following MCAo. The non-survivor group 
had the most profound decrease of 8.0 g from baseline (26.9 
J7KHORZHVWPHDQERG\ZHLJKWZDVJRQWKH
Tab. 3: Comparison of physiological measures among control, survivor and non-survivor groups  
(A) Middle cerebral artery occlusion (MCAo) stroke model, from the day animals underwent the MCAo procedure up to the 5th day 
SRVWVWURNH%OLSRSRO\VDFFKDULGH/36LQGXFHGVHSVLVPRGHOIURPWKHÀUVWLQMHFWLRQXSWRKDIWHUWKHÀUVWLQMHFWLRQ%DVHOLQH
PHDVXUHPHQWVZHUHFRQGXFWHGEHIRUHWKH0&$RVKDPWUHDWPHQWRUWKHÀUVW/36VDOLQHLQMHFWLRQ%DVHOLQHYDOXHVZHUHPHDVXUHGRQ 
WKHGD\RIWUHDWPHQW0RQLWRULQJSHULRGZDVGHÀQHGDVWKHst to 5th day post-stroke and the 1st to 8th day post-sepsis.
A
 Control (n = 66) Survivor (n = 322) Non-survivor (n = 58)
Baseline core temperature (°C)  35.7, 38.9 34.1, 38.9 28.0, 38.3 
min, max, mean (SD) 37.0 (0.8) 36.4 (1.0) 36.2 (1.9)
Core temperature during monitoring (°C) 33.7, 38.4 20.8, 38.4 17.8, 37.8 
min, max, mean (SD) 36.6 (0.9) 35.7 (1.6) 33.5 (3.7)
Baseline body weight (g) 16.0, 32.6 16.7, 34.9 14.5, 33.9 
min, max, mean (SD) 24.8 (3.2) 25.4 (3.3) 26.9 (3.7)
Body weight during monitoring (g) 16.1, 30.1 13.9, 31.0 14.3, 29.6 
min, max, mean (SD) 22.4 (2.4) 21.4 (3.0) 21.0 (3.1)
Baseline Neuroscore 0, 3 0, 4 0, 2 
min, max, mean (SD) 0.9 (1.0) 0.33 (0.8) 0.4 (0.9)
Neuroscore during monitoring 0, 17.0 0, 35 0, 41 
min, max, mean (SD) 4.9 (4.9) 9.1 (5.5) 15.4 (9.5)
B
 Control (n = 151) Survivor (n = 254) Non-survivor (n = 30)
Baseline surface temperature (°C) 27.0, 33.7 26.3, 33.8 27.5, 33.3 
min, max, mean (SD) 30.8 (1.1) 30.5 (1.6) 30.6 (1.4)
Surface temperature during monitoring (°C) 23.9, 36.5 20.3, 34.6 19.0, 31.7 
min, max, mean (SD) 30.6 (1.4) 29.1 (2.0) 25.7 (2.7)
Baseline body weight (g) 17.5, 26.9  14.9, 28.7 17.6, 24.3 
min, max, mean (SD) 21.5 (1.7) 21.5 (1.8) 21.4 (2.0)
Body weight during monitoring (g) 16.4, 27.6 13.2, 27.7 12.5, 23.3 
min, max, mean (SD) 21.9 (1.5) 19.7 (2.1) 18.8 (2.6)
Sickness score during monitoring 0, 2 0, 4 0, 4.5 
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nations of parameters. Apart from body weight, temperature, and 
sickness score/neuroscore, the absolute change per timepoint for 
these parameters was calculated by subtracting the baseline value 
from measured values at each timepoint, resulting in an addition-
al parameter set. The two sets of parameters were used in model 
training. 
Machine learning models were trained with individual param-
eters or combinations of physiological and behavioral parame-






was conducted separately for each gender.
,QWKHVHSVLVPRGHOVLFNQHVVVFRUHVRIWKHVXUYLYRUJURXSSHDN-
ed at 10.5 hours (1.2 (0.8)) and 12 hours (1.4 (0.9)) after the in-
jection on day 1 and 2, respectively, then returned to baseline 
OHYHOZLWKLQKRXUVIROORZLQJWKH¿UVW/36LQMHFWLRQ6LFNQHVV
scores of non-survivors increased after injection day 1 and peak-
HGDWKRXUVDIWHUWKHVHFRQGLQMHFWLRQ7KHVLFN-
QHVVVFRUHVDPRQJFRQWURODQLPDOVUHPDLQHGXQFKDQJHG7DE
3.2.4  Prediction of death from physiological  
measures 
To assess the performance of physiological and behavioral pa-
rameters such as body weight, temperature, and sickness severity 
VFRUHPRGL¿HG'H6LPRQLQHXURVFRUHLQGHDWKSUHGLFWLRQZHGH-
veloped an automated parameter search method to test the perfor-
mance of machine learning models trained with different combi-
Fig. 2: Decision boundaries determined by the machine learning model
The earliest time points (2 and 3 days or 24 h post-treatment in the stroke or sepsis model, respectively) at which impending death could  
be predicted with acceptable accuracy were included. Data from 36 h post-injection in the sepsis model was plotted for comparison 
purposes. Parameter-model combinations leading to highest prediction accuracy were plotted. (a) Decision boundary obtained with 
body weight change on the 1st and 3rd day after treatment and core body temperature change on the 3rd day after treatment. (b) Decision 




survivor); blue area, predicted survival; red area, predicted death. Gaussian Naïve Bayes (as in a and b), decision trees of depth 2 (as in c) 
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FLVLRQ IURP  WR   DQG DFFXUDF\ IURP
WRRIWKHWUDLQHGPRGHO
,QWKHVHSVLVPRGHOXVLQJERWKVLFNQHVVVFRUHDQGVXUIDFHWHP-
perature in model training improved accuracy and general per-
formance of the prediction model (Tab. 4b). At 24 hours after 
treatment, using sickness score in addition to surface tempera-
ture in model training led to an increase in sensitivity from 0.65 
(0.11) to 0.86 (0.12) and accuracy from 0.95 (0.01) to 0.96 (0.01), 
while model precision decreased slightly from 0.77 (0.17) to 0.75 
(0.11). 
Interaction between the use of multiple physiological  
measurements and time points
,QWKHVWURNHPRGHOGXHWRWKHORZSHUIRUPDQFHRIPRGHOVWUDLQHG
with combinations of physiological parameters obtained on the 
same day, data from different post-treatment days were used in 
combination in model training. This approach precluded the as-
sessment of an interaction between multiple parameters and indi-
vidual time points.
,QWKHVHSVLVPRGHOXVLQJPXOWLSOHSK\VLRORJLFDOSDUDPHWHUV
to train the predictive model enhanced the accuracy of death pre-
GLFWLRQDW LQGLYLGXDO WLPHSRLQWV:KHQ WKHPRGHOZDV WUDLQHG
ZLWKGDWDIURPKRXUVDIWHUWKH¿UVW/36LQMHFWLRQXVLQJVLFN-
ness score as an additional measure increased sensitivity and 
accuracy by 21.5% and 1.1%, respectively (Tab. 4b). No im-
provement in model performance was observed using data from 
KRXUVDIWHUWKH¿UVW/36LQMHFWLRQZKHQVLFNQHVVVFRUHVZHUH
included in model training (Tab. 4b). 
4  Discussion
2XUVWXG\UHYHDOHG WKUHHPDLQ¿QGLQJV)LUVWO\ WKHV\VWHPDWLF
review demonstrated remarkable heterogeneity of humane end-
points even within the same animal model due to lack of sys-
tematic assessment, protocol standardization, and/or ambiguous 
or incomplete description of results. This illustrates a distinct 
challenge in adopting humane endpoints from the literature and 
highlights the need for researchers to tailor humane endpoints 
based on the currently available evidence. Secondly, using data 
from mouse models of stroke and sepsis, we found that machine 
learning by means of an automated search for predictive parame-
ters, parameter combinations, and models and hyperparameters, 
can be used to accurately determine endpoint criteria and cut-off 
threshold values across models. Thirdly, when we applied these 
criteria retrospectively to the available derivation cohort data-
sets, we found that a large number of animals could have been 
euthanized at earlier time points in both stroke and sepsis mod-
els, thus potentially reducing otherwise unnecessary suffering. 
4.1  Systematic review
,QWKLVVWXG\ZHUHYLHZHGPRXVHVWXGLHVXVLQJKXPDQHHQG-
points based on body temperature, body weight and/or sickness 
VHYHULW\ VFRUH 7DE :H IRXQG WKDW WHPSHUDWXUHEDVHG HQG-
points are commonly applied both in acute and chronic disease 
Death as an outcome event could be predicted with consider-
DEOHDFFXUDF\RIPDOHRUIHPDOHLQWKHPRGHORI
stroke and 96.2% in the model of sepsis (Tab. 4a,b), with weight 
change on the 1stDQGrd day after treatment, core temperature 
FKDQJHRQWKHrd day after treatment (male, stroke model), or with 
neuroscore, weight change, and core temperature change on the 
2nd day after treatment (female, stroke model), and with surface 
WHPSHUDWXUHDQGVLFNQHVVVFRUHDWKRXUVDIWHUWKH¿UVWLQMHFWLRQ
VHSVLVPRGHO*DXVVLDQ1DwYH%D\HVPDOHDQGIHPDOHVWURNH
model), decision tree of a depth of 2 (with data from 24 hours 
DIWHU WKH ¿UVW LQMHFWLRQ VHSVLV PRGHO DQG  ZLWK GDWD IURP 
KRXUVDIWHUWKH¿UVWLQMHFWLRQVHSVLVPRGHOZHUHXVHGWRLGHQ-
tify decision boundaries shown in Figure 2.
,QPDOHPLFHRI WKHVWURNHPRGHORXWRIDQLPDOV WKDW










were falsely predicted to die (Fig. 2a,b).
,QWKHVHSVLVPRGHORXWRIDQLPDOVFRXOGKDYHEHHQHX-
thanized at an earlier time point (t = 24 hours post treatment for 
HDUOLHU HXWKDQDVLD DYHUDJH WLPH RI GHDWK RI WKH  DQLPDOV  
KRXUVSRVW WUHDWPHQWZKLOHRXWRIRI
/36WUHDWHGDQLPDOVWKDWVXUYLYHGXQWLOWKHHQGRIWKHH[SHULPHQW
were falsely predicted to die (Fig. 2c,d).
Prediction of death as an outcome event at different  
post-treatment time points




able level of accuracy until the 2nd IHPDOHPLFHRUrd (male 
PLFHGD\SRVW0&$R7DED,QWKHVHSVLVPRGHOSK\VLRORJ-
LFDOPHDVXUHVREWDLQHGKRXUVDIWHUWKH¿UVWLQMHFWLRQFRXOGQRW
predict death as an outcome event due to the low general perfor-
mance of the model at this time point (for details see Tab. 4b). 
Prediction of death by using single or multiple  
physiological measurements
,QWKHVWURNHPRGHODGGLQJDGGLWLRQDOSK\VLRORJLFDOSDUDPHWHUV
in model training increased death prediction performance (Tab. 
D,QPDOHPLFHDGGLQJZHLJKWFKDQJHRQWKHst day after treat-




ture change on the 2nd day after treatment in addition to weight 
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temperature, while the animal’s core temperature stays constant 
DVORQJDVWKHUPRUHJXODWRU\UHVSRQVHVDUHLQWDFW.XU],Q
addition, measurement location and handling stress may contrib-
ute to differences in cut-off values between studies. Some authors 
used restraining devices for probe-based surface temperature ac-
quisition. However, stress results in activation of the sympathet-
ic nervous system, which in turn leads to increased thermogene-
sis and vasoconstriction of skin vessels, resulting in an increase 
in body temperature within seconds of being restrained (Vianna 
and Carrive, 2005). Therefore, body temperature measurements 
could be confounded by repeated handling (Cabanac and Briese, 
1992). 
models due to their objectivity and ease of measurement. How-
ever, we found considerable variations in temperature cut-off val-






tions in ambient temperature. 
Ambient temperature is an important factor contributing to dif-
ferences between an animal’s core and surface temperature. The 
lower the ambient temperature, the lower an animal’s surface 
Tab. 4: Death prediction with single or multiple parameters at different time points  
(A) Middle cerebral artery occlusion (MCAo) stroke model. Prediction model, Gaussian Naïve Bayes. (B) Lipopolysaccharide (LPS)-induced 
sepsis model. Prediction model, decision tree with a depth = 2 (24 h) and a depth = 1 (36 h). Decision tree of depth 2 was not used for  
KDIWHUWKHÀUVWLQMHFWLRQGXHWRRYHUÀWWLQJIROGVWUDWLÀHGFURVVYDOLGDWLRQZDVXVHGWRHYDOXDWHWKHSHUIRUPDQFHRIWKHWUDLQHGPRGHO
Only performance of the most predictive parameters and model combinations is shown. Data shown are means (SD) of scores obtained 
from the 2- (stroke model) or 3- (sepsis model) fold cross-validation.
A 
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criteria) while sickness scores were mostly used independently 
RXWRIVWXGLHVXVHGDGGLWLRQDOFULWHULD,QVWXGLHVWKDWHYDO-
uated the use of a composite score derived from other parameters 
(i.e., the product of weight x body temperature), a higher predic-
tion accuracy was observed than when assessing parameters in-
GLYLGXDOO\7UDPPHOODQG7RWK5D\HWDO$XWKRUV
used various metrics to assess the performance of humane end-
points, which often precludes direct between-study comparison. 
7KHWKUHHPRVWFRPPRQPHWULFVZHUHVHQVLWLYLW\Q VSHFL¿F-
ity (n = 5), and percentage/number of mice exhibiting certain cri-
WHULDVLJQVQ ,QRXWRIWKHVWXGLHVKXPDQHHQGSRLQWV
were applied without being evaluated for reliability and/or per-
formance or without endpoint evaluation being reported by the 
authors. Therefore, researchers may fail to appreciate the validity 
and/or reproducibility of humane endpoint criteria. 
Taken together, traditional approaches in monitoring disease 
progression and predicting death suffer from high degrees of 
VWXG\ KHWHURJHQHLW\ ZKLFK FRQIRXQGV LGHQWL¿FDWLRQ RI FXWRII
values that can be applied to more than one study. 
4.2  Machine learning-based death prediction
,QDQH[SORUDWRU\DSSURDFKZHXVHGPDFKLQHOHDUQLQJDVDQDO-
ternative method for determining humane endpoints, which en-
DEOHGXVWRLGHQWLI\FDVHVSHFL¿FFXWRIIYDOXHVHYHQDFURVVDQL-
mal models without a fundamental change in methodology. Us-
ing body weight, sickness severity scores, and surface or core 
temperature data (for the sepsis or stroke model, respectively) 
from previously published studies and unpublished results, we 
WUDLQHG DPDFKLQH OHDUQLQJPRGHO IRU FDVHVSHFL¿F GHDWK SUH-
GLFWLRQ)LUVWZHLGHQWL¿HGWKHSDUDPHWHUFRPELQDWLRQVWKDWOHG
to a high accuracy in detecting animals at higher risk of death. 
:HWKHQGHWHUPLQHGWKHFXWRIIYDOXHVDQGDVVHVVHGWKHLUSHUIRU-
PDQFHXVLQJVWDQGDUGL]HGPHWULFV:HIRXQGWKDWRXWRI
(stroke model) and 25 out of 28 (sepsis model) animals that were 
Humane endpoints based on rapid (over a few days) or gradu-
al (over extended periods of time leading to emaciation) weight 
loss relative to baseline are easy to adopt and are widely applied. 
However, weight-based endpoints are suboptimal in highly acute 
models of disease (i.e., circulatory shock) due to an animal’s rap-
LG GHWHULRUDWLRQZKLFKPD\ SUHFHGHZHLJKW ORVV /RXLH HW DO
.UDUXSHWDO1HP]HNHWDO,QDGGLWLRQWUXH
weight loss may be masked by debilitating conditions such as as-
cites or tumor growth (Nemzek et al., 2004).
6LFNQHVVVHYHULW\VFRUHVVHUYHDVDVLPSOL¿HGFODVVL¿FDWLRQRI
the physiological state of an animal, allowing systematic docu-
mentation of disease progression and humane endpoint evalua-
tion. However, manual scoring suffers from subjectivity and is 
prone to high degrees of inter-observer bias (Morton, 2000). 
Another factor contributing to high study heterogeneity is the 
lack of standardized schedules for animal inspection. Even for 
identical animal models, authors rarely used measurement sched-
ules which were consistent with previously published data (Nun-
DPDNHUHWDODE)XUWKHUPRUHRQO\DPLQRULW\RIVWXGLHV
RXWRIGHVFULEHGWKHH[DFWWLPHVUHODWLYHWREDVHOLQHDQGRU
experimental intervention when temperature, body weight, and/
or sickness score values were taken. Other variables potentially 
adding to study heterogeneity but only described by few studies 




otype, sex and developmental stage (described in all reviewed 
VWXGLHV6DQFKH]$ODYH]HWDO7UDPPHOODQG7RWK
To counter the uncertainty in endpoint evaluation caused 
by variation of individual parameters, 15 of the reviewed stud-
ies used a combination of more than one humane endpoint cri-
terion. Body weight was most commonly applied in combina-
WLRQZLWKDGGLWLRQDOFULWHULDRXWRIVWXGLHVXVHGDGGLWLRQDO
Tab. 5: Summary of endpoint criteria, advantages and disadvantages of weight-, body temperature-, and severity score-based 
humane endpoints
Humane endpoint Studies included Endpoint  Advantages Disadvantages
Weight-based  RIEDVHOLQH ïHDV\DGPLQLVWUDWLRQ ïSRRUSHUIRUPDQFHLQ 
  ERG\ZHLJKW ïKLJKREMHFWLYLW\ ïacute disease models 
    ïKLJKKDQGOLQJVWUHVV
Core   && ïKLJKREMHFWLYLW\ ïKLJKYDULDQFHGXHWR 
temperature-based   ïKLJKDFFXUDF\ ïDQDQLPDO·VWKHUPR 
   ïFRQWLQXRXVPRQLWRULQJ ïregulatory responses 
   ïORZKDQGOLQJVWUHVV ïand handling stress
Surface  && ïKLJKREMHFWLYLW\ ïKLJKYDULDQFHGXHWR 
temperature-based   ïKLJKDFFXUDF\ ïDQDQLPDO·VWKHUPR 
   ïORZKDQGOLQJVWUHVV ïregulatory responses  
    ïand handling stress
Severity score-based  0XOWLSOHFULWHULD ïHDV\DGPLQLVWUDWLRQ ïUHTXLUHVIDPLOLDULW\ 
   ïVLPSOLÀHGFODVVLÀFDWLRQ ïLQWHUREVHUYHUYDULDELOLW\ 
   ïRISK\VLRORJLFDOVWDWHV ïWLPHFRQVXPLQJ 
   ïV\VWHPDWLF ïKLJKKDQGOLQJVWUHVV 
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FKLQHOHDUQLQJZHLGHQWL¿HGKXPDQHHQGSRLQWVWKDWZRXOGKDYH
allowed earlier euthanasia of animals, thus potentially reducing 
an animal’s distress, suffering, and pain. Although the method 
still requires further validation, this exploratory study showed 
that machine learning-based humane endpoint criteria have the 
potential to be applied across various disease models. This may 
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'RQDWK6$Q-/HH6//HWDO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,QWHUDFWLRQRI$5&
and Daxx: A novel endogenous target to preserve motor func-
euthanized or died at later timepoints during the experiments 
could have been euthanized 1.08 days (stroke model, male), 2.25 
days (stroke model, female) or 1.45 days (sepsis model) earlier 
if endpoints determined by machine learning had been applied. 
7RRXUNQRZOHGJHWKLVLVWKH¿UVWVWXG\XVLQJDPDFKLQHOHDUQ-
ing approach to systematically determine humane endpoints in 
mouse models of acute disease and there is no previous data to 
compare our results to. 
3RWHQWLDO DGYDQWDJHV RI D PDFKLQH OHDUQLQJEDVHG DSSURDFK
for humane endpoint evaluation include improved standardiza-
tion and comparability of results as identical metrics can be ap-
SOLHGDFURVVVWXGLHV,QDGGLWLRQPDFKLQHOHDUQLQJLQWKLVVHWWLQJ
requires little expert knowledge and is relatively easy to apply. 
2QFHDPRGHOLVWUDLQHGZLWKVXI¿FLHQWGDWDDQLPDOWHFKQLFLDQV
and investigators can run the model with a simple command line 
tool to determine whether an animal has an increased risk of 
death, for example by visualizing decision boundaries (e.g., as 
shown in Fig. 2). Thus, machine learning may constitute a prom-
LVLQJWRROWRLPSURYHWKHUH¿QHPHQWRIKXPDQHHQGSRLQWVLQDQ-
imal studies of acute disease. However, the availability of da-
ta which can be used to train and/or validate machine learning 
PRGHOVWRHYDOXDWHDQGUH¿QHKXPDQHHQGSRLQWVDFURVVGLVHDVH
models is limited as only very few authors choose to make their 
raw data available in open data repositories.
4.3  Limitations of the present study
,Q WKHV\VWHPDWLFUHYLHZZHH[FOXGHGUHVHDUFKDUWLFOHV LQ ODQ-
guages other than English and results published in the form of 
conference abstracts, posters and talks. This introduces a poten-
tial source of publication and result bias. A particular concern 
for the machine learning-based analysis was missing data and 
a small number of animals which reached a humane endpoint 
criterion. Nevertheless, for humane endpoint evaluation small 
datasets and missing data represent the real-world scenario. One 
solution is to increase the frequency of inspections during criti-
cal phases, not only to ensure that disease progression is prop-
erly monitored, but to obtain a larger dataset for training death 
prediction models. To this end, some authors suggest the use of 
biotelemetry systems with implanted transmitters, which allow 
FRQWLQXRXVGDWDDFTXLVLWLRQ/HRQHWDO/DVWO\ZHDS-
plied machine learning-derived endpoint criteria to the deriva-
tion cohort, which may introduce results bias. Although a strat-
L¿HG FURVVYDOLGDWLRQZDV XVHG WR RSWLPL]H JHQHUDOL]DELOLW\ LW
ZRXOGEHEHQH¿FLDOIRUIXWXUHVWXGLHVWRLQFOXGHDQLQGHSHQGHQW




The degree of heterogeneity between studies using body tem-
perature, weight and sickness scores to determine or evaluate 
humane endpoint criteria was high. This may preclude authors 
from adopting appropriate cut-off values from previously pub-
lished studies and underscores the necessity for researchers to 
tailor the humane endpoints to the animal model and experi-
PHQWDOGHVLJQEHLQJXVHG ,QDQDSSURDFKDLPHGDW HQKDQFLQJ
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